Drug use in Ireland & Northern Ireland 2006/2007: drug prevalence survey bulletin 2: Regional Drugs Task Force (Ireland) & Health and Social Services Board (Northern Ireland) results. by unknown
This bulletin presents key findings at a local level from the second drug prevalence survey of households in both 
Ireland and Northern Ireland. The survey sampled a representative number of people aged between 15 and 64 
during late 2006 and early 2007. The survey was carried out by Ipsos MORI in Ireland and by the Central Survey 
Unit of the Northern Ireland Statistics and Research Agency in Northern Ireland according to standards set by the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). This bulletin presents results relating to 
drug prevalence on a lifetime, last year (recent) and last month (current) basis for illegal and other drugs 
including alcohol and tobacco for each Regional Drugs Task Force area (RDTF)1 in Ireland, and Health and  
Social Services Board (HSSB) in Northern Ireland.
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■ Lifetime use of any illegal drugs varied 
across RDTF and HSSB areas ranging 
from as high as 38% in RDTF and 
37% in HSSB areas to as low as 14% 
in RDTF and 20% in HSSB areas.
■ Last year prevalence rates for any 
illegal drugs showed a four fold 
difference between the highest and 
lowest rate in RDTFs (13% and 3%) 
whereas the difference was smaller  
in HSSB areas (13% and 7%).
■ These differences widened for last 
month use of any illegal drugs in both 
RDTF and HSSB areas.  The highest 
rate at 8% being 27 times greater 
than the lowest rate of 0.3% in RDTF 
areas whereas in HSSB areas the 
difference was smaller with the 
highest rate being 3 times greater  
6% than the lowest rate 2%.
■ Prevalence rates for use of any illegal 
drugs tended to be higher across all 
time periods in the East Coast and 
Southern RDTFs in Ireland and in the 
Eastern HSSB in Northern Ireland.
1 For explanation please see footnote on page 5.
■ Cannabis was the most commonly 
used illegal drug in all RDTF and HSSB 
areas across all time periods.
■ Prevalence rates for all other illegal 
drugs were considerably lower than 
the rates for cannabis use in all RDTF 
and HSSB areas.
■ In general, the profile of illegal drug 
users across RDTF and HSSB areas was 
similar: men were more likely than 
women and young adults more likely 
than older adults to use illegal drugs.
■ Significant changes in illegal drug use  
since the 2002/3 survey varied across 
RDTF and HSSB areas. For example, 
lifetime use of cannabis increased  
in 2 RDTF and HSSB areas, whereas 
lifetime use of cocaine increased in  
5 of the 10 RDTF areas and in all  
4 HSSB areas.
2 National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2008
Drug Use in Ireland & Northern Ireland 2006/2007 Drug Prevalence Survey:  
Regional Drugs Task Force (Ireland) & Health and Social Services Board (Northern Ireland) Results Bulletin 2
National Advisory Committee on Drugs (NACD) & Public Health Information and Research Branch (PHIRB) June 2008
Northern Ireland Key Findings by  
Health and Social Services Board (HSSB)
■ Among all adults aged 15-64 years, lifetime prevalence rates 
for any illegal drugs varied across HSSB areas, ranging from 
20% in the WHSSB to 37% in the EHSSB.
■ The highest last year prevalence rate for any illegal drugs 
(13%) was almost double that of the lowest rate (7%) 
among all adults.
■ Among all adults, last month prevalence rates for any illegal 
drugs ranged from 2% in the NHSSB and WHSSB to 6% in 
the EHSSB.
■ Prevalence rates tended to be higher across all time periods 
in the EHSSB than in other HSSB areas.
■ Cannabis was the most commonly used illegal drug in all 
HSSB areas across all time periods.
■ Generally, prevalence rates for other illegal drugs were 
considerably lower than the rates for cannabis use in  
all HSSB areas.
■ After cannabis, ecstasy was the most commonly reported 
illegal drug ever used in the EHSSB and SHSSB, while 
poppers were the most commonly reported illegal drug  
ever used in the NHSSB and WHSSB.
■ In the last year, ecstasy was the most commonly reported 
illegal drug used in the EHSSB after cannabis; in all other 
HSSB areas, cocaine was the most commonly reported illegal 
drug after cannabis.
■ The profile of illegal drug users was similar across HSSB 
areas: in general, men were more likely than women, and 
young adults were more likely than older adults, to use any 
illegal drugs.
■ Some changes since 2002/3 were statistically significant:  
in the EHSSB, lifetime prevalence rates for any illegal drugs 
increased from 22.5% in 2002/3 to 36.6% in 2006/7 and 
for cannabis use, from 18.9% to 32.2%, among all adults.
■ Significant increases since the previous survey in the last year 
use of any illegal drugs were observed in the EHSSB among 
all adults (from 7.3% to 12.6%), males (from 11.0% to 
18.3%) and young adults (from 13.3% to 23.4%).
■ Among all adults, lifetime use of cocaine increased 
significantly in all HSSB areas.
■ Last year use of cocaine increased significantly among all 
adults since 2002/3 in three of the HSSB areas: in the 
EHSSB (from 1.0% to 2.8%), in the NHSSB (from 0.0%  
to 1.1%) and in the WHSSB (from 0.2% to 1.7%).
■ Among all adults, lifetime use of cannabis increased significantly 
since the previous survey in the EHSSB and NHSSB.
■ Last year use of cannabis increased significantly among 
females in the SHSSB.
■ Since 2002/3, current use of ecstasy increased among 
females in the EHSSB but decreased among all adults  
and males in the NHSSB.
■ Current use of tobacco decreased among all adults in  
the EHSSB, SHSSB and WHSSB.
■ There were significant decreases since 2002/3 in the lifetime 
and last year prevalence rates for alcohol among young 
adults in the SHSSB.
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■ Lifetime use of any illegal drugs varied across RDTF areas 
ranging from 38% in the East Coast RDTF, to as low  
as 14% in the North Western RDTF.
■ The highest prevalence rate (13%) was four-times greater 
than the lowest prevalence rate (3%), for last year use of 
any illegal drugs.
■ This gap widened for last month use with the range from 8% 
in the Northern Area RDTF, to 0.3% in the North Western 
RDTF, a 27 fold difference.
■ Prevalence rates (any illegal drugs) tended to be higher 
across all time periods in the east of the country from 
Dundalk to Cork.
■ Cannabis was the most commonly used illegal drug in all 
RDTF areas across all time periods.
■ Prevalence rates for all other illegal drugs were considerably 
lower than the rates for cannabis use in all RDTF areas.
■ In RDTF areas cocaine ranks, on average, the 4th most 
commonly used drug after cannabis (1st), magic mushrooms 
(2nd) and ecstasy (3rd) for lifetime use.
■ Last year use of cocaine on average ranks second after 
cannabis, followed by ecstasy (3rd) and magic mushrooms 
(4th).
■ The profile of illegal drug users was similar in all areas: more 
men than women and more young adults than older adults 
use illegal drugs.
■ Some changes since 2002/3 were statistically significant.  
For example the Western RDTF had an almost doubling  
of lifetime prevalence among all adults for any illegal drug 
use, from 12.5% in 2002/3 to 23.3% in 2006/7, and for 
cannabis use from 12.0% in 2002/3 to 21.0% in 2006/7.
■ Significant increases since 2002/3 for last year use were 
observed among all adults in the East Coast RDTF for any 
illegal drug use, from 6.3% in 2002/3 to 12.4% in 2006/7 
and among older adults from 2.3% to 7.0%. Similarly, last 
year use of cannabis increased among all adults from 6.1% 
to 11.3% and for older adults from 1.9% to 6.5%.
■ Lifetime use of cocaine increased significantly in five RDTF areas.
■ Lifetime use of magic mushrooms increased significantly  
in three RDTF areas.
■ Statistically significant decreases were observed in the 
lifetime use of amphetamines, LSD and tobacco  
in the South Western RDTF area.
■ There was a significant decrease in lifetime use of alcohol  
in the Southern RDTF area.
■ However, three RDTFs (the Midland, the North East and the 
North West) showed an increase in lifetime use of alcohol 
among older adults.
■ Three RDTF areas showed significant increases in lifetime  
use of alcohol among women.
■ Conversely, in the Southern Area RDTF last month use  
of alcohol significantly decreased among women.
■ In the Northern Area RDTF both lifetime and last year use  
of tobacco decreased significantly among women.
■ There were more increases observed among older adults 
than among young adults:
 (i) Lifetime use of any illegal drugs increased among older 
adults in four RDTFs compared to increases among 
young adults in just three RDTF areas.
 (ii) Lifetime use of cannabis increased in three RDTF areas 
for older adults and in two RDTF areas for young adults.
Ireland Key Findings by  
Regional Drugs Task Force (RDTF)
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NWRDTF
L 14.5
LY 2.9
LM 0.3
MWRDTF
L 18.0
LY 5.8
LM 1.4
MRDTF
L 19.6*
LY  4.4
LM 1.7
WRDTF
L 23.3*
LY 4.7
LM 1.6
NERDTF
L 22.9
LY 5.7
LM 1.1
NRDTF
L 32.2
LY 12.8
LM 8.2
SERDTF
L 25.4
LY 7.9
LM 3.6
SRDTF
L 16.3
LY  4.9
LM 2.0
ECRDTF
L 38.4*
LY 12.4*
LM 5.3
SWRDTF
L 25.6
LY 7.4
LM 2.0
NHSSB
L 24.8*
LY 7.2
LM 1.6
SHSSB
L 21.6
LY 7.4
LM 3.8
WHSSB
L 20.3
LY 7.6
LM 2.1
EHSSB
L 36.6*
LY 12.6*
LM 5.6
L = Lifetime
LY = Last Year
LM = Last Month
* Statistically significant 
increase since 2002/3
Map 1: 
Use of any illegal drugs: Prevalence rates for all adults aged 15-64 in RDTF and HSSB areas 2006/7
Purple boundary and shading highlights the RDTF areas.
HSSB areas are highlighted in pink shading.
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Introduction
The survey was commissioned by the National Advisory 
Committee on Drugs (NACD) in Ireland and the Public Health 
Information and Research Branch (PHIRB), formerly known as 
the Drug and Alcohol Information and Research Unit (DAIRU), 
within the Department of Health, Social Services and Public 
Safety (DHSSPS) in Northern Ireland.
The main focus of the survey was to obtain prevalence rates for 
key illegal drugs, such as cannabis, ecstasy, cocaine and heroin, 
on a lifetime (ever used), last year (recent use), and last month 
(current use) basis. Similar prevalence questions were also asked 
of alcohol, tobacco, and other drugs (e.g. tranquillisers); attitudinal 
and demographic information was also sought from respondents.
Methodology
The questionnaire and methodology for this survey were based 
on best practice guidelines drawn up by the EMCDDA. The 
questionnaires were administered through face-to-face interviews 
with respondents aged between 15 and 64 normally resident  
in households in Ireland and Northern Ireland. Thus persons 
outside these age ranges, or who do not normally reside in 
private households, have not been included in the survey. This 
approach is commonly used throughout the EU and because of 
the exclusion of those living in institutions (for example, prisons, 
hostels) this type of prevalence survey is usually known as a 
general population survey.
Fieldwork for the survey was carried out between October 2006 
and May 2007 and the final achieved sample was 6,969 (4,967 
in Ireland and 2,002 in Northern Ireland). The response rate for 
the survey was 65% in Ireland and 62% in Northern Ireland. Area 
based sampling was applied in Ireland. The first stage involved 
stratifying by Health Board2/Regional Drugs Task Force (RDTF) 
area in Ireland. Within the Health Board/RDTF strata Electoral 
Divisions (EDs) were selected as areas. In Northern Ireland, the 
first stage involved stratifying by Health and Social Services Board 
(HSSB) areas and within the strata simple random sampling was 
used. The achieved sample was weighted by gender, age, RDTF 
area in Ireland and HSSB area in Northern Ireland, to maximise 
representativeness of the general population. The effects of 
stratification, clustering and weighting have been incorporated  
in the interval estimates (i.e. design effect adjusted). Details  
2 Since January 2005 the Health Boards in Ireland have undergone 
restructuring and are merged under one authority – the Health Service 
Executive. However for the purpose of comparison with 2002/3 data, we 
have continued to weight the data by the former Health Board areas as 
these correspond with the Regional Drugs Task Force (RDTF) structures. 
The above reference relates to the Health Board structures details in 
Bulletin 2: Drug Use in Ireland and Northern Ireland 2002/2003 Drug 
Prevalence Survey – Health Board (Ireland) & Health and Social Services 
Board (Northern Ireland) Results (Revised) June, 2005. 
of the methodology have been published on the websites  
of the NACD (http://www.nacd.ie/) and the DHSSPS (http://
www.dhsspsni.gov.uk/) in comprehensive technical reports 
containing copies of the questionnaires used in each jurisdiction.
The Research Advisory Group (RAG) decided to change from 
using a pen and paper interviewing technique to computer-
assisted personal interviewing (CAPI), where the interviewer 
records responses electronically. This technique has several 
advantages: interviews can be administered more quickly;  
human error is minimised; yielding higher-quality data; and  
data input is managed more efficiently, thus cutting costs.3
Please Note:
■ Prevalence rates for “any illegal drugs” refers to the reported 
use of one or more of the following: amphetamines, 
cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic 
mushrooms, poppers or solvents – see table footnotes.
■ Questions relating to Nubain® were asked only in Northern 
Ireland. To maintain comparability of overall illegal drug 
prevalence rates between Ireland and Northern Ireland, this 
drug is not included in the calculation of the prevalence rates 
for “any illegal drugs”.
■ There was a change in the measurement of ‘other opiates’  
in Ireland between 2002/3 and 2006/7. In 2002/3 ‘other 
opiates’ included 9 drugs: Opium, Temgesic®, Diconal®, 
Napps, MSTs®, Pethidine, DF118® (Dihydrocodeine), 
Buprenorphine and Morphine. In 2006/7 the category ‘other 
opiates’ was extended to be consistent with Northern Ireland, 
it included: Codeine, Kapake, Diffs, Dikes, Peach, Fentanyl 
(Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, 
Oxynorm®), and Buprenorphine (Subutex®). The 2006/7 
results for this drug category are reported in this bulletin but 
given this change in measurement, comparative analysis 
between 2002/3 and 2006/7 is not appropriate.
■ The measurement of the combined group of sedatives, 
tranquillisers and anti-depressants was changed between 
2002/3 and 2006/7. In 2002/3 this drugs category was 
measured using one question while in 2006/7 two questions 
were used. Furthermore in 2006/7 a more expansive list of 
drug categories was used (see technical report for further 
details). Given this change in measurement comparative 
analysis between 2002/3 and 2006/7 is not appropriate.
3 EMCDDA Handbook on Population Surveys 2002.
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What is Prevalence?
The term prevalence refers to the proportion of a 
population who has used a drug over a particular time 
period. In general population surveys, prevalence is 
measured by asking respondents in a representative 
sample drawn from the population to recall their use  
of drugs. The three most widely used recall periods are: 
lifetime (ever used a drug), last year (used a drug in the 
last twelve months), and last month (used a drug in the 
last 30 days). Provided a sample is representative of the 
total population, prevalence information obtained from a 
sample can be used to infer prevalence in the population.
Lifetime prevalence refers to the proportion of the 
sample that reported ever having used the named drug 
at the time they were surveyed. A person who records 
lifetime prevalence may – or may not – be currently 
using the drug. Lifetime prevalence should not be 
interpreted as meaning that people have necessarily 
used a drug over a long period of time or that they  
will use the drug in the future.
Last year prevalence refers to the proportion of the 
sample that reported using a named drug in the year 
prior to the survey. For this reason, last year prevalence 
is often referred to as recent use.
Last month prevalence refers to the proportion of the 
sample that reported using a named drug in the 30 day 
period prior to the survey. Last month prevalence is 
often referred to as current use. A proportion of those 
reporting current use may be occasional (or first-time) 
users who happen to have used in the period leading 
up to the survey – it should therefore be appreciated 
that current use is not synonymous with regular use.
As with other European surveys, people over the age of 64 are 
excluded from this survey, as they grew up in an era when both 
the use and availability of illegal drugs were very limited. Therefore 
surveys with older people have, to date, shown very low rates of 
use even on a lifetime basis. This situation will change over time 
as the younger population grows older. Hence lifetime prevalence 
rates are likely to increase for a considerable period time. When 
examining the data and comparing results over time, last year 
use is the best reflection of changes as it refers to recent use. 
Last month use is equally valuable as it refers to current use.
Understanding the Results in 
this Bulletin
Results (revised) from the first Drug Prevalence Survey, 
published in Bulletin 2 (June 2005), gave comparative 
information for Ireland and its constituent Health Boards (and 
RDTF areas) and Northern Ireland and its constituent Health and 
Social Services Boards. This bulletin contains the same information 
for 2006/7 and also provides comparison information between 
2002/3 and 2006/7. Results are given for all respondents, and 
are also presented by gender and by age (young adults aged 15-
34 and older adults aged 35-64). All prevalence rates presented 
in the accompanying tables are rounded to one decimal place 
and are rounded to whole numbers in the text (except for 
percentages less than 1%). Changes in prevalence rates 
between 2002/3 and 2006/7 are also rounded to one decimal 
place and reported in this format in the text.
As in all sample surveys, the greater the sample size the more 
statistically reliable are the results. Some of the differences in 
prevalence rates in the tables will be attributable to natural 
sample variations. Detailed confidence intervals for all prevalence 
figures contained in this bulletin can be found on the websites  
of the NACD and DHSSPS (see page 5).
Invalid responses have been excluded from all analyses. 
Percentages may not always sum to 100 due to either the effect of 
rounding or where respondents could give more than one answer.
Where the figure 0.0% appears it does not mean that no-one 
has used the drug, rather it means that in this category no 
respondent reported use. The confidence intervals will provide  
a prevalence rate for all categories of drug use.
Statistical significance tests have been carried out on the drug 
prevalence data in this bulletin. These tests are used to establish 
the degree of confidence with which we can infer that observed 
changes in drug prevalence between 2002/3 and 2006/7 are not 
due to sampling error. In this bulletin, a significance level of 5% 
has been specified which means that the likelihood that sampling 
error accounts for the observed changes is less than 5%.
A population drug prevalence survey has limitations. The more 
problematic drug users may also be underrepresented due to 
the complicated and problematic nature of their lives. Therefore, 
population drug prevalence surveys are not used to estimate  
the prevalence of problem drug use (i.e. heroin or crack use). 
Whilst this survey includes some young people, it needs to be 
supplemented by a school survey of the teenage population 
such as the European School Survey Project on Alcohol and 
Other Drugs (ESPAD) in Ireland or the Young Persons’ Behaviour 
and Attitudes Survey (YPBAS) in Northern Ireland.
A summary of key results for the four Health and Social Services 
Board areas in Northern Ireland (see map 2) and the ten Regional 
Drugs Task Force areas in Ireland (see map 3) are given below.
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Northern Ireland – Results 
by Health and Social 
Services Board
Prevalence rates for Northern Ireland are given in Tables 1.1,  
1.2 and 1.3.
Map 2: Northern Ireland  
– Health and Social Services Board Areas
DONEGAL
CAVAN
MONAGHAN
LOUTH
MEATH
LONGFORD
LEITRIM
SLIGO
ROSCOMMON
GALWAY
MAYO
North
Western
RDTF
Mid-
Western
RDTF
Midland
RDTF
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RDTF
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Eastern
RDTF
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RDTF
Southern
RDTF
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EAST COAST RDTF
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WESTMEATH
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Northern
HSSB
Southern
HSSB
Western
HSSB Eastern
HSSB
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(EHSSB)
(See Tables 2.1, 2.2 and 2.3)
Any illegal drugs
More than a third (37%) of respondents reported ever having 
taken any illegal drugs, 13% had done so in the previous year 
and 6% in the previous month. Among all adults aged 15-64 in 
the EHSSB, the prevalence rates for any illegal drugs were higher 
than the corresponding figures for Northern Ireland. Males were 
more likely than females to report lifetime use (47% compared 
to 27%) and last year use (18% compared to 7%) of any illegal 
drugs. Similarly, young adults aged 15-34 were more likely than 
their older counterparts (aged 35-64) to report lifetime use 
(54% compared to 24%) and last year use (23% compared  
to 5%) of any illegal drugs.
Cannabis
Cannabis was the most commonly used illegal drug, with nearly 
one third (32%) of respondents reporting ever having taken it. 
Nine percent had taken it in the previous year and 4% in the 
previous month. Males were more likely than females to report 
lifetime use (40% compared to 25%) and last year use (12% 
compared to 6%). A similar pattern was evident with young 
adults and older adults: lifetime use (46% compared to 22%) 
and last year use (14% compared to 5%).
Other illegal drugs
Apart from cannabis, the highest levels of lifetime use were 
recorded for ecstasy (11%), magic mushrooms, LSD and poppers 
(each 10%), amphetamines and cocaine (each 7%), and solvents 
(5%). The lifetime prevalence of all other illegal drugs was less 
than 1% – heroin (0.8%) and crack (0.4%). In the last year, 
ecstasy and cocaine (each 3%), poppers and amphetamines 
(each 2%) were the main drugs reported other than cannabis.  
In the month prior to the survey, ecstasy (2%) was the most 
frequently reported illegal drug used apart from cannabis.
Sedatives, tranquillisers and anti-depressants
Almost one quarter of respondents reported ever using sedatives 
and tranquillisers (24%) and anti-depressants (24%). In the 
previous year 11% reported using sedatives and tranquillisers 
and 9% reported using anti-depressants. Just under one in ten 
respondents reported using sedatives and tranquillisers (8%) 
and anti-depressants (8%) in the previous month. Females were 
more likely than males to have used anti-depressants in each of 
the timescales examined. Older adults reported higher lifetime, 
last year and last month prevalence rates for both sedatives, 
tranquillisers and anti-depressants than young adults.
Other opiates, anabolic steroids and Nubain®
Over one quarter (28%) of respondents reported lifetime use of 
other opiates, 11% reported use in the previous year and 6% in 
the previous month. Males and females were just as likely to report 
use of other opiates in each of the timescales examined. Older 
adults (aged 35-64) were more likely than young adults (aged 
15-34) to have ever used other opiates (34% compared to 20%).
Lifetime prevalence of anabolic steroids was 1%, while there was 
no reported use in the previous year or the previous month in 
the EHSSB.
There was no reported use of Nubain® in the EHSSB.
Alcohol
Ninety percent of the respondents in the EHSSB area reported 
that they had ever taken alcohol, 82% had done so in the 
previous year and 76% in the previous month. Males (81%) 
were more likely to report current drinking than females (71%), 
while young adults (77%) and older adults (76%) had similar 
current drinking prevalence rates.
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Tobacco
Fifty nine percent of respondents reported ever smoking 
tobacco, 35% had done so in the previous year and 30% in the 
previous month. Male respondents were more likely to report 
ever having smoked than females (63% compared to 54%), 
whereas similar proportions of males (31%) and females 
(30%) reported current smoking. Young adults were more likely 
than their older counterparts to report smoking in the last year 
(42% compared to 30%).
EHSSB – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 22.5% in 
2002/3 to 36.6% in 2006/7 among all adults (15-64 years). 
There were increases in lifetime use of any illegal drugs among 
males (from 29.8% to 46.5%), females (from 15.5% to 
27.2%), young adults (from 33.7% to 54.1%) and older adults 
(from 13.7% to 24.1%).
Among all adults aged 15-64, lifetime use of the following drugs 
increased since the previous survey: cannabis (from 18.9% to 
32.2%), heroin (from 0.1% to 0.8%), cocaine (from 2.3% to 
7.2%), LSD (from 5.1% to 9.5%), magic mushrooms (from 
4.3% to 10.4%) and solvents (from 2.4% to 4.7%).
Increases were found among males in lifetime use of cannabis 
(from 26.2% to 40.3%), cocaine (from 4.0% to 10.7%), LSD 
(from 8.1% to 14.8%) and magic mushrooms (from 5.7% to 
18.0%). Among females, lifetime prevalence rates increased 
since the previous survey for cannabis (from 12.0% to 24.5%) 
and cocaine (from 0.7% to 3.8%).
Among young adults, lifetime use of the following drugs increased 
since 2002/3: cannabis (from 27.4% to 46.2%), cocaine (from 
4.5% to 12.8%) and magic mushrooms (from 5.7% to 13.3%). 
Increases were found among older adults for cannabis (from 
12.3% to 22.1%), heroin (from 0.0% to 0.8%), cocaine (from 
0.7% to 3.1%), LSD (from 2.3% to 5.7%), magic mushrooms 
(from 3.2% to 8.4%) and solvents (from 1.2% to 3.6%).
Significant Changes – Last Year Prevalence
Last year use of any illegal drugs increased from 7.3% in 
2002/3 to 12.6% in 2006/7 among all adults (15-64 years). 
There were increases in last year use of any illegal drugs among 
males (from 11.0% to 18.3%) and young adults (from 13.3% 
to 23.4%).
Among all adults aged 15-64, there were increases in the last 
year use of cocaine (from 1.0% to 2.8%) and poppers (from 
0.6% to 2.3%) since the previous survey.
Increases were found among males in last year use of poppers 
(from 0.8% to 4.0%). Among females, last year prevalence 
rates increased since the previous survey for cocaine (from 
0.2% to 1.7%) and amphetamines (from 0.3% to 1.7%). 
There were decreases in last year tobacco use among females 
(from 40.4% to 32.0%) and older adults (from 38.6% to 
30.1%) since 2002/3.
Significant Changes – Last Month Prevalence
There were increases in last month use of any illegal drugs 
among females (from 1.2% to 3.8%) and older adults (from 
1.2% to 3.9%) since 2002/3.
Among all adults aged 15-64, last month use of tobacco 
decreased since the previous survey, from 37.4% to 30.3%.
Increases were found among females in last month use of ecstasy 
(from 0.2% to 1.7%) and among older adults in last month use 
of cannabis (from 0.9% to 3.5%). There were decreases in last 
month tobacco use among females (from 38.3% to 29.9%) 
and older adults (from 35.7% to 27.1%) since 2002/3.
Northern Health and Social Services Board 
(NHSSB)
(See Tables 3.1, 3.2 and 3.3)
Any illegal drugs
One quarter (25%) of respondents reported ever having taken 
any illegal drugs, 7% had done so in the previous year and 2% 
in the previous month. Among all adults aged 15-64 in the 
NHSSB, the last month prevalence rate for any illegal drugs was 
significantly lower than the corresponding figure for Northern 
Ireland. Males were more likely than females to report lifetime 
use (29% compared to 21%) and last year use (10% 
compared to 4%) of any illegal drugs while young adults aged 
15-34 reported higher lifetime, last year and current usage rates 
than older adults aged 35-64.
Cannabis
Cannabis was the most commonly used illegal drug, with 22% 
of respondents reporting ever having taken it. Seven percent 
had taken it in the previous year and 2% in the previous month. 
Males were more likely than females to report lifetime use 
(26% compared to 18%) and last year use (10% compared  
to 3%) while young adults reported higher lifetime, last year 
and last month prevalence rates than their older counterparts.
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Other illegal drugs
With the exception of cannabis, the highest levels of lifetime  
use were recorded for poppers (8%), LSD, magic mushrooms, 
ecstasy and amphetamines (each 6%), cocaine (4%), and 
solvents (2%). The lifetime prevalence rates of all other illegal 
drugs were less than 1% – crack (0.6%) and heroin (0.1%). In 
the year prior to the survey, cocaine (1%) was the main drug 
reported other than cannabis – no other drug had a last year 
prevalence rate exceeding 1%. In the month prior to the survey, 
amphetamines (0.2%) were the only other illegal drugs used 
apart from cannabis.
Sedatives, tranquillisers and anti-depressants
One fifth of respondents reported ever taking sedatives and 
tranquillisers (20%) and anti-depressants (21%). In the previous 
year, almost one in ten respondents reported taking sedatives and 
tranquillisers (9%) and anti-depressants (9%) – the corresponding 
figures for current usage of sedatives, tranquillisers and anti-
depressants were 7% each. Males were just as likely as females to 
report use of sedatives and tranquillisers in each of the timescales 
examined, whereas the lifetime prevalence rate for females taking 
anti-depressants was more than twice that for males (28% 
compared to 13%). Older adults aged 35-64 were more likely than 
young adults aged 15-34 to report use of sedatives and tranquillisers 
in their lifetime, in the last year and in the last month. Current use 
of anti-depressants among older adults was more than twice that 
of younger adults (9% compared to 4%).
Other opiates, anabolic steroids and Nubain®
One fifth (20%) of respondents reported taking other opiates in 
their lifetime, 8% reported use in the previous year and 5% in 
the previous month. A higher proportion of females (26%) than 
males (15%) reported lifetime use of other opiates. Young 
adults were just as likely as older adults to report use of other 
opiates in each of the timescales examined.
One percent of respondents reported taking anabolic steroids in 
their lifetime, 0.5% in the last year and 0.5% in the last month.
No respondents reported taking Nubain®, in any timescale, in 
the NHSSB.
Alcohol
Eighty eight percent of the respondents in the NHSSB area 
reported that they had ever taken an alcoholic drink, 80% had 
done so in the previous year and 67% in the previous month. 
Males (73%) were more likely to report current drinking than 
females (60%), while young adults and older adults had similar 
lifetime, last year and current drinking prevalence rates.
Tobacco
Fifty five percent of respondents reported ever smoking tobacco, 
35% had done so in the previous year and 30% in the previous 
month. Male respondents (61%) were more likely to report ever 
having smoked than females (49%). A higher proportion of 
young adults than their older counterparts reported smoking  
in the year prior to the survey (41% compared to 30%).
NHSSB – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 17.8% in 2002/3 
to 24.8% in 2006/7 among all adults (15-64 years). There were 
increases in lifetime use of any illegal drugs among females 
(from 12.7% to 21.0%) and older adults (from 9.1% to 15.9%).
Among all adults aged 15-64, there were increases in the 
lifetime use of cannabis (from 14.4% to 22.2%) and cocaine 
(from 1.0% to 3.8%) since the previous survey.
Increases were found among males in lifetime use of cocaine (from 
2.1% to 5.6%). Among females, lifetime prevalence rates increased 
since the previous survey for cannabis (from 9.3% to 18.3%), 
cocaine (from 0.0% to 1.9%) and LSD (from 1.4% to 4.4%).
Among young adults, there were increases in the lifetime use of 
cannabis (from 22.8% to 33.8%) and cocaine (from 1.3% to 
6.7%) since 2002/3. Increases were found among older adults 
for cannabis (from 8.1% to 14.4%) and anabolic steroids (from 
0.0% to 1.2%).
Significant Changes – Last Year Prevalence
Among all adults aged 15-64, there was an increase in the last year 
use of cocaine (from 0.0% to 1.1%) since the previous survey.
Increases were found among males in last year use of cocaine 
(from 0.0% to 2.0%). Among young adults, the last year 
prevalence rate increased since the previous survey for cocaine 
(from 0.0% to 1.9%).
Significant Changes – Last Month Prevalence
Last month use of any illegal drugs decreased among males, 
from 6.5% to 2.0%, since 2002/3.
Among all adults aged 15-64, last month use of ecstasy 
decreased since the previous survey, from 1.1% to 0.0%.
Decreases were found among males in last month use of 
cannabis (from 6.2% to 2.0%) and ecstasy (from 2.2% to 
0.0%). There was a decrease in last month tobacco use among 
females (from 35.3% to 27.3%) since 2002/3.
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Southern Health and Social Services Board 
(SHSSB)
(See Tables 4.1, 4.2 and 4.3)
Any illegal drugs
Just over one fifth (22%) of respondents reported ever having 
taken any illegal drugs, 7% had done so in the previous year and 
4% in the previous month. Among all adults aged 15-64 in the 
SHSSB, the lifetime prevalence rate for any illegal drugs was 
significantly lower than the corresponding figure for Northern 
Ireland. Males were more likely to report lifetime, last year and 
current use of any illegal drugs than females. Young adults aged 
15-34 had higher prevalence rates than older adults aged 35-64 
for use of any illegal drugs in each of the timescales examined.
Cannabis
Cannabis was the most commonly reported illegal drug, with 
around one in five (19%) respondents reporting ever having 
taken it. Seven percent had taken it in the previous year and 4% 
in the previous month. Males were more likely than females to 
report lifetime use (23% compared to 14%), last year use (10% 
compared to 4%) and last month use (5% compared to 2%). 
Young adults reported higher lifetime, last year and last month 
prevalence rates than their older counterparts.
Other illegal drugs
Other than cannabis, the highest levels of lifetime use were 
recorded for ecstasy and poppers (each 5%), amphetamines 
(4%), cocaine, magic mushrooms, solvents and LSD (each 3%). 
Lifetime prevalence for all other illegal drugs was below 1% - 
heroin and crack (each 0.6%) and methadone (0.2%). In the 
year prior to the survey, cocaine (1%) was the main drug 
reported other than cannabis – no other drug had a last year 
prevalence rate exceeding 1%. Use of ecstasy, cocaine, magic 
mushrooms and poppers was reported by less than 1% of 
respondents in the last month.
Sedatives, tranquillisers and anti-depressants
Eighteen percent of respondents reported ever using anti-
depressants, 9% had done so in the previous year and 7% in the 
previous month. Prevalence rates for sedatives and tranquillisers 
were as follows: 15% for lifetime use, 7% for recent use and 
5% for current use. Female lifetime, last year and last month 
prevalence rates for anti-depressants were at least double those 
of males. Females were also more likely than males to report last 
year and last month use of sedatives and tranquillisers. Older 
adults reported higher lifetime, last year and current usage rates 
for sedatives and tranquillisers than young adults and also higher 
lifetime prevalence rates for anti-depressants.
Other opiates, anabolic steroids and Nubain®
Eleven percent of respondents in the SHSSB area reported that 
they had ever taken other opiates, 6% in the last year and 3% in 
the previous month. Similar proportions of males and females 
reported having taken other opiates at some time in their life 
(10% compared to 12%), in the last year (5% compared to 
7%) and in the last month (4% compared to 3%). Young adults 
aged 15-34 were just as likely as older adults aged 35-64 to 
report use of other opiates in each of the timescales examined.
One percent of respondents reported ever taking anabolic 
steroids and 0.1% reported using them in the last year.
There was no reported use of Nubain® in the SHSSB.
Alcohol
Eighty one percent of the respondents in the SHSSB area reported 
that they had ever taken an alcoholic drink, 74% had done so in 
the previous year and 63% in the previous month. Males (84%) 
were more likely to report lifetime drinking than females (78%), 
and both these rates were lower than the corresponding Northern 
Ireland figures. Young adults were just as likely as older adults to 
report drinking alcohol in each of the timescales examined.
Tobacco
Half of respondents (50%) reported ever smoking tobacco, 30% 
had done so in the previous year and 26% in the previous month. 
Male respondents (55%) were more likely to report ever having 
smoked than females (46%). Young adults reported higher last 
year and current smoking prevalence rates than older adults.
SHSSB – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Among all adults aged 15-64, there were increases in the 
lifetime use of cocaine (from 0.8% to 3.3%) since the previous 
survey. Lifetime use of alcohol decreased from 85.7% to 80.9% 
among all adults.
Increases were found among males in lifetime use of cocaine 
(from 1.4% to 5.2%). Among females, the lifetime prevalence 
rate for amphetamines increased from 0.5% to 2.8% since the 
previous survey.
Among young adults, there was an increase since 2002/3 in 
lifetime use of cocaine (from 1.5% to 6.3%) and a decrease  
in the use of alcohol (from 89.3% to 81.6%). An increase was 
found among older adults for poppers (from 0.5% to 3.2%).
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Significant Changes – Last Year Prevalence
Among all adults aged 15-64, there was a decrease in the last year 
tobacco use (from 38.6% to 29.6%) since the previous survey.
An increase was found among females in last year use of 
cannabis (from 0.7% to 4.0%) and a decrease in last year 
tobacco use (from 35.3% to 25.9%). Among young adults,  
the last year alcohol prevalence rate decreased from 85.0% to 
75.3% since the previous survey. A decrease was found among 
older adults for last year tobacco use (from 36.5% to 24.4%).
Significant Changes – Last Month Prevalence
Among all adults aged 15-64, last month use of cannabis 
increased from 1.5% to 3.5% since 2002/3 while tobacco use 
decreased from 35.2% to 26.4%.
There were increases in last month use of cannabis among 
females (from 0.0% to 1.8%) and among young adults (from 
2.9% to 7.8%) since 2002/3. Decreases were found in last 
month use of tobacco since the previous survey among males 
(from 37.4% to 28.3%), females (from 33.0% to 24.6%) and 
older adults (from 33.5% to 21.6%).
Western Health and Social Services Board 
(WHSSB)
(See Tables 5.1, 5.2 and 5.3)
Any illegal drugs
One fifth (20%) of respondents reported ever having taken any 
illegal drugs, 8% had done so in the previous year and 2% in the 
previous month. Among all adults aged 15-64 in the WHSSB, the 
lifetime prevalence rate for any illegal drugs was significantly lower 
than the corresponding figure for Northern Ireland. Males were 
more likely than females to report higher lifetime (24% compared 
to 17%) and last year (12% compared to 3%) prevalence rates. 
Young adults aged 15-34 had higher lifetime and last year usage 
rates of any illegal drugs than older adults aged 35-64.
Cannabis
Cannabis was the most commonly used illegal drug, with 18% 
of respondents reporting ever having taken it. Five percent had 
taken cannabis in the previous year and 1% in the previous 
month. Males were more likely than females to report lifetime 
use (22% compared to 15%) and last year use (8% compared 
to 2%). Young adults also reported higher lifetime and last year 
prevalence rates than their older counterparts.
Other illegal drugs
With the exception of cannabis, the highest levels of lifetime  
use were recorded for poppers and ecstasy (each 7%), 
amphetamines and cocaine (each 5%), LSD and magic 
mushrooms (each 4%) and solvents (3%). The lifetime 
prevalence of both heroin and methadone was 0.2%. In the  
last year, the main drugs reported apart from cannabis were 
cocaine (2%), ecstasy and poppers (each 1%). In the month 
prior to the survey, all illegal drugs other than cannabis were 
used by less than 1% of respondents.
Sedatives, tranquillisers and anti-depressants
Similar proportions of respondents reported ever using sedatives 
and tranquillisers (17%) and anti-depressants (18%). Males 
were just as likely as females to report lifetime, last year and last 
month usage of sedatives and tranquillisers. Almost twice as 
many females than males reported taking anti-depressants at 
some point in their life or in the last year; more than twice as 
many females (11%) reported current use of anti-depressants 
than males (4%). For both groups of drugs, older adults showed 
higher prevalence rates than younger adults, in all timescales.
Other opiates, anabolic steroids and Nubain®
In the WHSSB, 13% of respondents reported taking other 
opiates in their lifetime, 6% in the past year and 3% in the 
month prior to the survey. Males were just as likely as females  
to report lifetime, last year and last month use of other opiates. 
Older adults reported higher prevalence rates than young adults 
for other opiates in each of the timescales.
Anabolic steroids had reportedly been used by 0.6% of 
respondents at some time in their life, 0.3% in the last year  
and 0.1% in the last month.
No respondents reported taking Nubain®, in any timescale,  
in the WHSSB.
Alcohol
Eighty seven percent of respondents in the WHSSB area reported 
that they had ever taken an alcoholic drink, 79% had done so in 
the previous year and 66% in the previous month. Males (70%) 
were more likely to report current drinking than females (62%) 
and these prevalence rates are similar to the corresponding figures 
for Northern Ireland as a whole. The same proportion of young 
adults and older adults reported current drinking (66%).
Tobacco
Fifty four percent of respondents reported ever smoking tobacco, 
33% had done so in the previous year and 30% in the previous 
month. Similar proportions of male and female respondents 
reported lifetime (55% compared to 53%), last year (32% 
compared to 33%) and current smoking (31% compared to 29%). 
Young adults were just as likely as older adults to report ever having 
smoked, having smoked in the last year and in the last month.
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WHSSB – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 9.9% in 2002/3 
to 16.5% in 2006/7 among older adults aged 35-64.
Among all adults aged 15-64, there was an increase in the 
lifetime use of cocaine (from 1.5% to 4.6%) since the previous 
survey and a decrease in tobacco use (from 63.4% to 53.9%).
Increases were found among females in lifetime use of cocaine 
(from 0.8% to 4.2%) and amphetamines (from 1.4% to 4.8%) 
since 2002/3. Lifetime use of tobacco decreased from 66.2% 
to 55.2% among males.
Among young adults, there was an increase since 2002/3 in 
lifetime use of cocaine (from 2.9% to 7.6%) and a decrease  
in the use of tobacco (from 60.8% to 50.2%). Increases were 
found among older adults for the following drugs: cannabis 
(from 9.2% to 14.8%), cocaine (from 0.2% to 2.3%), 
amphetamines (from 0.6% to 3.0%), ecstasy (from 0.3% to 
3.6%), LSD (from 0.9% to 3.5%) and poppers (from 0.6% to 
3.9%). Lifetime use of tobacco decreased from 65.6% to 57.0% 
since the previous survey among older adults.
Significant Changes – Last Year Prevalence
Among all adults aged 15-64, there was an increase in last year use 
of cocaine (from 0.2% to 1.7%) and a decrease in the last year 
tobacco use (from 44.7% to 32.6%) since the previous survey.
Last year use of cocaine increased from 0.4% in 2002/3 to 
3.0% in 2006/7 among young adults. Decreases in last year 
tobacco use were found among males (from 44.6% to 31.7%), 
females (from 44.8% to 33.4%), young adults (from 48.7% to 
32.3%) and older adults (from 41.3% to 32.8%).
Significant Changes – Last Month Prevalence
Among all adults aged 15-64, last month tobacco use decreased 
from 40.7% to 30.2% since 2002/3. Decreases were also 
found in last month use of tobacco since the previous survey 
among males (from 40.1% to 31.3%), females (from 41.4%  
to 29.0%) and young adults (from 43.3% to 29.3%).
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Ireland –Results by Regional 
Drugs Task Force Area (RDTF)
Prevalence rates for Ireland are given in Table 7.1, 7.2 and 7.3.
Map 3: Ireland – Regional Drugs Task Force Areas
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(See Tables 8.1, 8.2 and 8.3)
Any illegal drugs
Over one third (38%) of respondents reported having ever taken 
any illegal drugs: 12% had done so in the previous year, and 5% 
in the previous month. Among all adults aged 15-64 in the 
ECRDTF area, the prevalence rates for any illegal drugs were higher 
than the corresponding national figures. Males were more likely 
than females to report lifetime use (45% compared to 32%),  
last year use (14% compared to 11%) and last month use (7% 
compared to 4%) of any illegal drugs. Young adults aged 15-34 
had higher prevalence rates than older adults aged 35-64 for 
use of any illegal drugs in each of the time periods examined.
* ERHA – Eastern Regional Health Authority which comprised three RDTFs 
covering East Dublin and Wicklow, North Dublin and South West Dublin, 
Kildare and West Wicklow.
Cannabis
Cannabis was the most commonly used illegal drug; 36%  
of respondents reported ever taking the drug, 11% had done  
so in the previous year, and 4% in the previous month. Males 
reported higher prevalence rates than females across all three 
time periods examined. Young adults aged 15-34 were more 
likely than older adults aged 35-64, to report lifetime use (38% 
compared to 34%), last year use (16% compared to 6%) and 
last month use (6% compared to 3%) of cannabis. All cannabis 
prevalence rates were higher in the ECRDTF area than the 
corresponding national rates.
Other illegal drugs
Apart from cannabis, highest levels of lifetime use were recorded 
for magic mushrooms (11%), cocaine powder (9%), ecstasy 
(8%), poppers (5%), LSD and amphetamines (each 4%). 
Lifetime prevalence rates for all of these drugs were higher  
than the corresponding national rates.
Last year prevalence rates for cocaine powder (3%), ecstasy  
and magic mushrooms (each 2%) were also higher than the 
corresponding national rates.
In the month prior to the survey, aside from cannabis, cocaine 
powder (1%) was the most widely reported drug used. Low 
levels of current use of ecstasy (0.5%) and poppers (0.3%) 
were reported by those surveyed.
Sedatives, tranquillisers and anti-depressants
Twelve percent of respondents reported ever using sedatives and 
tranquillisers; 5% had done so in the previous year and 2% in the 
previous month. Females were more likely than males to report 
lifetime use (17% compared to 7%), last year use (7% compared 
to 4%) and current use (4% compared to 0.7%). Older adults 
lifetime, last year and last month prevalence rates for sedatives 
and tranquillisers were at least double those of young adults.
The lifetime prevalence rate for anti-depressants was 8%;  
last year use was 4% and 3% reported last month use.
Other opiates
Thirteen percent of respondents reported the lifetime use  
of other opiates, 5% in the previous year and 2% in the 
previous month. These prevalence rates were higher than the 
corresponding national rates. Female lifetime, last year and last 
month prevalence rates for other opiates were at least double 
those of males. Older adults were more likely than young adults 
to report lifetime use (15% compared to 11%) and last year  
use (5% compared to 4%) of other opiates.
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Alcohol
Ninety three percent of respondents surveyed reported ever taking 
alcohol; 86% had done so in the previous year, and 77% in the 
previous month. Alcohol prevalence rates across age and gender 
were slightly higher than the corresponding national prevalence 
rates. Young adults were more likely than older adults to report 
recent use (88% compared to 84%) and current use (78% 
compared to 76%) of alcohol. Males reported higher prevalence 
rates than females across all three time periods examined.
Tobacco
Sixty percent of respondents reported having ever smoked 
tobacco, 39% had done so in the previous year, and 32% in the 
previous month. Males were more likely than females to report 
lifetime use (61% compared to 59%), last year use (41% 
compared to 36%) and last month use (35% compared to 
29%). Young adults reported higher recent and current smoking 
prevalence rates than older adults.
ECRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 25.9% in 
2002/3 to 38.4% in 2006/7 among all adults (15-64 years), 
from 18.0% to 34.4% among older adults (aged 35-64) and 
from 17.6% to 31.9% among females since the previous survey.
Among all adults aged 15-64 there were increases in the lifetime 
use of cannabis (from 24.5% to 35.9%) and magic mushrooms 
(from 5.9% to 10.9%) since the last survey.
Increases among older adults (35-64 years) were found  
in lifetime use of cannabis (from 17.4% to 33.7%), magic 
mushrooms (from 2.9% to 7.3%), cocaine powder (from 3.0% 
to 7.2%) and poppers (from 0.7% to 3.2%). Among females, 
increases since the previous survey were found in lifetime use  
of cannabis (from 16.4% to 29.5%), magic mushrooms (from 
3.1% to 10.3%) and cocaine powder (from 2.0% to 6.9%).
Significant Changes – Last Year Prevalence
Last year use of any illegal drugs increased from 6.3% in 
2002/3 to 12.4% in 2006/7 among all adults (15-64 years). 
There were increases in last year use of any illegal drugs among 
those aged 35-64 years (from 2.3% to 7.0%) and among 
females (from 2.5% to 11.1%).
Since the previous survey increases were found among all adults 
(aged 15-64) in last year use of cannabis (from 6.1% to 11.3%), 
and magic mushrooms (from 0.0% to 2.0%). Last year use of 
cannabis also increased among those aged 35-64 years (from 
1.9% to 6.5%) and among females (from 2.5% to 9.0%).
Midland Regional Drugs Task Force (MRDTF)
(See Tables 9.1, 9.2 and 9.3)
Any illegal drugs
One fifth (20%) of respondents reported having ever taken any 
illegal drugs; 4% had done so in the previous year, and 2% in 
the previous month. Among all adults aged 15-64 in the MRDTF 
area, the prevalence rates for any illegal drugs were lower than 
the corresponding national figures. Males were more likely than 
females to report lifetime use (24% compared to 15%), last 
year use (6% compared to 3%) and last month use (2% 
compared to 1%) of any illegal drugs. Young adults aged 15-34 
had higher prevalence rates than older adults aged 35-64 for 
use of any illegal drugs in each of the time periods examined.
Cannabis
Cannabis was the most commonly used illegal drug, 17% of 
respondents reported ever taking the drug, 4% had done so in 
the previous year, and 1% in the previous month. Males were 
more likely than females to have used cannabis in each of the 
time periods examined. Young adults had higher lifetime, last 
year and last month prevalence rates than older adults. All 
cannabis prevalence rates were lower in the MRDTF area than 
the corresponding national rates.
Other illegal drugs
Apart from cannabis, highest levels of lifetime use were recorded 
for ecstasy (6%); magic mushrooms (5%); cocaine powder and 
amphetamines (each 4%); solvents and poppers (each 3%); 
and LSD (2%).
Cocaine powder and ecstasy (each 1%) were the most commonly 
reported drugs used in the last year. In the month prior to survey 
cocaine powder (1%) was the most widely reported drug used.
Sedatives, tranquillisers and anti-depressants
Twelve percent of respondents reported ever using sedatives and 
tranquillisers, 5% had done so in the previous year and 3% in 
the previous month. Lifetime, last year and last month 
prevalence rates among females and older adults were higher 
than the corresponding national figures.
Ten percent of respondents in the MRDTF reported having ever 
used anti-depressants, 3% had done so in the previous year, and 
3% in the previous month. Lifetime and last month prevalence 
rates among females were higher than the corresponding 
national rates.
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Other opiates
Five percent of respondents reported ever using other opiates, 
1% had done so in the previous year, and 1% in the previous 
month. Females reported a higher lifetime prevalence rate than 
males (9% compared to 2%). Older adults were more likely 
than young adults to report lifetime use (8% compared to 2%), 
last year use (2% compared to 0.4%) and last month use (1% 
compared to 0%) of other opiates.
Alcohol
Ninety one percent of respondents surveyed reported ever having 
taken alcohol, 84% had done so in the previous year, and 70% 
in the previous month. Males were more likely than females to 
report last year use (86% compared to 81%) and last month 
use (74% compared to 67%) of alcohol. Young adults reported 
higher last year and last month prevalence rates than older adults. 
Overall, rates were similar to the national prevalence rates, 
although last month usage rates across gender and age within 
the MRDTF were lower than the corresponding national rates.
Tobacco
Sixty percent of respondents reported having ever smoked 
tobacco, 39% had done so in the previous year, and 36% in the 
previous month. Lifetime, last year and last month prevalence 
rates were higher among young adults than older adults, and 
exceeded the national rates across all three time periods. 
Females were more likely than males to report last year use 
(42% compared to 37%) of tobacco. There was no gender 
difference in current smoking.
MRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 11.0% in 
2002/3 to 19.6% in 2006/7 among all adults (15-64 years). 
There were increases in lifetime use of any illegal drugs among 
young adults aged 15-34 (from 15.2% to 27.7%) and among 
men (from 13.3% to 23.9%).
Among all adults aged 15-64, lifetime use of the following drugs 
increased since the previous survey: ecstasy (from 2.0% to 
5.8%); magic mushrooms (from 1.8% to 5.5%); amphetamines 
(from 0.6% to 3.6%); and cocaine powder (from 1.3% to 4.0%).
Since the previous survey, increases were found among young 
adults (15-34 years) in lifetime use of magic mushrooms (from 
2.9% to 10.5%) and ecstasy (from 3.4% to 10.5%). Increases 
among older adults (35-64 years) were found in lifetime use of 
alcohol (from 85.1% to 91.8%) and amphetamines (from 0.0% 
to 2.7%). Among males, increases were found in lifetime use of 
magic mushrooms (from 2.8% to 9.6%) and ecstasy (from 2.6% 
to 8.7%). Among females, lifetime use of alcohol increased 
(from 81.3% to 90.8%).
Mid-Western Regional Drugs Task Force 
(MWRDTF)
(See Table 10.1, 10.2 and 10.3)
Any illegal drugs
Eighteen percent of respondents reported having ever taken any 
illegal drugs; 6% had done so in the previous year, and 1% in 
the previous month. Among all adults aged 15-64 in the 
MWRDTF, the prevalence rates for any illegal drugs were lower 
than the corresponding national figures. Males were more likely 
than females to report lifetime use (22% compared to 14%), last 
year use (8% compared to 4%) and last months use (3% 
compared to 0%) of any illegal drugs. Young adults aged 15-34 
had higher prevalence rates than older adults aged 35-64 for use 
of any illegal drugs in each of the three time periods examined.
Cannabis
Cannabis was the most commonly used illegal drug, 17% of 
respondents reported ever taking it, 5% had done so in the 
previous year, and 1% in the previous month. Males were more 
likely than females to report lifetime use (21% compared to 
13%), last year use (7% compared to 3%) and last month 
usage (3% compared to 0%) of cannabis. Young adults were at 
least twice as likely as older adults to report cannabis use across 
all time periods examined. Rates of cannabis use within the 
MWRDTF area were lower than the corresponding national rates.
Other illegal drugs
Apart from cannabis, highest levels of lifetime use were recorded 
for magic mushrooms, ecstasy, cocaine powder and amphetamines 
(each 3%); and LSD, solvents and poppers (each 2%).
Poppers, cocaine powder, ecstasy and amphetamines (each 1%) 
were the most commonly reported drugs used in the past year. 
Current use of ecstasy and LSD (each 0.3%) was low.
Sedatives, tranquillisers and anti-depressants
Nine percent of respondents reported ever using sedatives and 
tranquillisers, 4% had done so in the previous year and 2% in 
the previous month. Males were as likely as females to report 
current use of sedatives and tranquillisers (2%). However, 
females were at least twice as likely as males to report lifetime 
use (13% compared to 5%) and last year use (6% compared 
to 3%). Older adults reported higher prevalence rates than 
young adults, across the three time periods examined.
Ten percent of respondents reported having ever used anti-
depressants, 4% had done so in the previous year, and 2% in 
the previous month.
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Other opiates
Six percent of respondents reported ever using other opiates; 
3% had used other opiates in the previous year, and 1% in the 
previous month. Young adults were more likely than older adults 
to report last year use (5% compared to 1%) and last month 
use (2% compared to 0.2%). Lifetime, last year and last month 
prevalence rates among older adults were lower than the 
corresponding national rates. Conversely, among young adults 
prevalence rates across the three time periods were higher than 
national figures.
Alcohol
Ninety percent of respondents surveyed in the MWRDTF reported 
that they had ever taken alcohol, 83% had done so in the 
previous year, and 72% in the previous month. Young adults aged 
15-34 were more likely than older adults ages 35-64 to report use 
of alcohol in their lifetime, in the last year and in the last month. 
Alcohol prevalence rates within the MWRDTF were broadly similar 
to the corresponding national rates, although older adults reported 
slightly lower rates for last year and last month use.
Tobacco
Sixty percent of respondents reported having ever smoked 
tobacco, 39% had done so in the previous year, and 36% in the 
previous month. Young adults were more likely than older adults 
to report last year use (40% compared to 38%) and current use 
(38% compared to 34%) of tobacco. Males were more likely 
than females to report recent and current smoking.
MWRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Last Year Prevalence
Among all adults aged 15-64 there was a small, albeit significant 
increase in last year use of poppers (from 0.0% to 1.3%).
North Eastern Regional Drugs Task Force 
(NERDTF)
(See Tables 11.1, 11.2 and 11.3)
Any illegal drugs
Twenty three percent of respondents reported having ever taken 
any illegal drugs; 6% had done so in the previous year, and 1% 
in the previous month. Among all adults aged 15-64 in the 
NERDTF, the prevalence rates for any illegal drugs were lower 
than the corresponding national figures. Males were more likely 
than females to report lifetime use (29% compared to 16%), 
last year use (8% compared to 3%) and last month use (2% 
compared to 0.3%) of any illegal drugs. Young adults reported 
higher prevalence rates than older adults, across the three time 
periods examined.
Cannabis
Cannabis was the most commonly used illegal drug: 19% of 
respondents reported ever taking the drug, 5% had done so  
in the previous year, and 1% in the previous month. These 
prevalence rates were lower than the corresponding national 
figures. Males reported higher prevalence rates than females 
across the three time periods. Young adults were more likely 
than older adults to report lifetime use (25% compared to 
15%), last year use (8% compared to 2%) and last month  
use (2% compared to 0.7%) of cannabis.
Other illegal drugs
After cannabis, lifetime use of ecstasy, magic mushrooms, and 
cocaine powder was reported (each 5%), amphetamines, 
poppers and LSD (each 3%), and solvents (2%).
After cannabis cocaine powder, ecstasy and poppers (each 1%) 
were the most commonly reported drugs used in the past year. 
Other than cannabis, poppers (0.2%) and heroin (0.1%) were 
the only drugs currently used by those surveyed.
Sedatives, tranquillisers and anti-depressants
Ten percent of respondents within the NERDTF reported ever 
using sedatives and tranquillisers, 5% had done so in the 
previous year and 3% in the previous month. Females were  
at least twice as likely as males to report the use of sedatives 
and tranquillisers across the three time periods examined. Older 
adults were more likely than young adults to report lifetime use 
(15% compared to 3%), last year use (8% compared to 2%) 
and current use (5% compared to 1%).
Eight percent of respondents reported having ever used anti-
depressants, 4% had done so in the previous year, and 2% in 
the previous month. Males and young adults within NERDTF 
reported lower prevalence rates than the corresponding national 
figures, across all three time periods.
Other opiates
Four percent of respondents reported ever using other opiates, 
1% had done so in the previous year, and 0.3% in the previous 
month. Females were more likely than males to report lifetime, 
last year and last month use of other opiates. However, all 
prevalence rates were lower than the corresponding national rates.
Alcohol
Ninety one percent of respondents surveyed reported that they 
had ever taken alcohol, 84% had done so in the previous year, 
and 73% in the previous month. Males reported higher current 
use of alcohol than females (80% compared to 66%).
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Tobacco
Fifty eight percent of respondents reported having ever smoked 
tobacco, 37% had done so in the previous year, and 35% in the 
previous month. Lifetime, last year and last month prevalence 
rates were higher among males and young adults than the 
corresponding national rates. Conversely, the prevalence rates  
for females across the three time periods were lower than the 
national figures. Young adults were more likely than older adults 
to report last year use (44% compared to 32%) and current use 
(41% compared to 30%) of tobacco.
NERDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased among older adults aged 
35-64 in the NERDTF from 7.2% in 2002/3 to 17.6% in 2006/7.
Among all adults aged 15-64, lifetime use of cocaine powder 
increased (from 0.9% to 4.9%) since the previous survey.
Increases were found among young adults aged 15-34 in 
lifetime use of cocaine powder (from 1.5% to 8.7%) since the 
previous survey. Increases among older adults (35-64 years) 
were found in lifetime use of cannabis (from 6.7% to 14.9%) 
and alcohol (from 85.1% to 91.9%). Among males, lifetime  
use of cocaine powder increased (from 1.8% to 7.4%). Among 
females, there were increases in lifetime use of alcohol (from 
84.1% to 90.7%) and cocaine powder (from 0.0% to 2.3%).
North Western Regional Drugs Task Force 
(NWRDTF)
(See Table 12.1, 12.2 and 12.3)
Any illegal drugs
Fourteen percent of respondents reported having ever taken any 
illegal drugs; 3% had done so in the previous year, and 0.3% in 
the previous month. Prevalence rates within the NWRDTF were 
lower than national rates across age and gender. Males were more 
likely than females to report lifetime use (18% compared to 11%) 
and last year use (4% compared to 2%) of any illegal drugs. 
Young adults aged 15-34 reported higher prevalence rates than 
older adults aged 35-64 across the three time periods examined.
Cannabis
Cannabis was the most commonly used illegal drug; 13% of 
respondents reported ever taking the drug, 3% had done so in 
the previous year, and 0.3% in the previous month. Females 
were more likely than males to report current cannabis use 
(0.6% compared to 0%). Rates of cannabis use within the 
NWRDTF area were lower than the corresponding national rates.
Other illegal drugs
After cannabis, highest levels of lifetime use were reported for magic 
mushrooms and poppers (each 3%), ecstasy, amphetamines, 
solvents and cocaine powder (each 2%), LSD, crack cocaine heroin 
(each 1%). Current use of ecstasy, cocaine powder and crack was 
low and reported by 0.3% of respondents. Recent and current 
prevalence rates were highest among females and young adults.
Sedatives, tranquillisers and anti-depressants
Twelve percent of respondents reported ever using sedatives and 
tranquillisers, 6% had done so in the previous year and 4% in the 
previous month. Among all adults aged 15-64 in the NWRDTF, the 
prevalence rates for sedatives and tranquillisers were higher than 
the corresponding national figures. Older adults were twice as 
likely as young adults to report lifetime, last year and current use. 
Females reported higher prevalence rates than males across the 
three time periods examined.
Ten percent of respondents reported having ever used anti-
depressants, 5% had done so in the previous year, and 4% in 
the previous month. Lifetime, last year and last month prevalence 
rates were higher than the national rates among males and older 
adults. Females were more likely than males to report lifetime use 
(13% compared to 7%) and last year use (6% compared to 
4%) of anti-depressants. Older adults reported higher prevalence 
rates than young adults in each of the time periods examined.
Other opiates
Eight percent of respondents reported ever using other opiates, 
3% had done so in the previous year, and 0.4% in the previous 
month. Among all adults aged 15-64 in the NWRDTF, lifetime 
and last year prevalence rates for other opiates were higher than 
the corresponding national figures. Females were more likely 
than males to report lifetime use (9% compared to 7%) of 
other opiates. Older adults reported higher prevalence rates  
than young adults across the three time periods examined.
Alcohol
Ninety percent of respondents surveyed reported that they had 
ever taken alcohol, 79% had done so in the previous year, and 
65% in the previous month. Recent and current prevalence rates 
were lower than national figures across age and gender. Young 
adults were more likely than older adults to report last year use 
(80% compared to 77%) and current use (70% compared to 
61%) of alcohol. Males reported higher last year and last month 
alcohol use than females.
Tobacco
Fifty six percent of respondents reported having ever smoked 
tobacco, 32% had done so in the previous year, and 28%  
in the previous month. Prevalence rates were lower than the 
corresponding national rates, in particular recent use (30% 
compared to 36%) and current use (26% compared to 32%) 
among females.
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NWRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of the following drugs increased among all adults 
aged 15-64 since the previous survey: ecstasy (from 0.3% to 
2.2%); amphetamines (from 0.3% to 2.1%); and cocaine 
powder (from 0.0% to 1.6%)
Across age groups and gender: increases (since the previous 
survey) were found among older adults (35-64 years) in lifetime 
use of alcohol (from 84.2% to 90.8%). Among females, lifetime 
use of alcohol also increased (from 81.0% to 90.2%) since the 
previous survey.
Northern Regional Drugs Task Force (NRDTF)
(See Tables 13.1, 13.2 and 13.3)
Any illegal drugs
Almost one third (32%) of respondents reported having ever 
taken any illegal drugs; 13% had done so in the previous year, 
and 8% in the previous month. Among all adults aged 15-64 in 
the NRDTF, the prevalence rates for any illegal drugs were higher 
than the corresponding national figures. Young adults were at 
least twice as likely as older adults to report the use of any illegal 
drugs across all three time periods. Lifetime, last year and last 
month prevalence rates were higher among males than females.
Cannabis
Cannabis was the most commonly used illegal drug; 29% of 
respondents reported ever taking the drug: 12% had done so  
in the previous year and 8% in the previous month. Prevalence 
rates were highest among young adults and males. Rates of 
cannabis use were higher than the corresponding national rates, 
across gender and age groups.
Other illegal drugs
After cannabis, the highest levels of lifetime use were recorded 
for magic mushrooms, ecstasy, and cocaine powder (each 11%); 
LSD, poppers and amphetamines (each 6%); methadone, 
solvents and heroin (each 1%); and crack cocaine (0.5%).  
With the exception of solvents and crack, prevalence rates for  
all other illegal drugs across age groups and gender, were higher  
than the corresponding national figures.
After cannabis, cocaine powder and ecstasy (each 3%) and 
amphetamines, magic mushrooms and poppers (each 1%) were the 
most commonly reported drugs used in the past year. In the month 
prior to survey, use of cocaine powder, ecstasy and methadone 
(each 1%) were the main drugs reported other than cannabis  
– no other drug had a last month prevalence rate exceeding 1%.
Sedatives, tranquillisers and anti-depressants
Eleven percent of respondents reported ever using sedatives and 
tranquillisers, 4% had done so in the previous year and 2% in 
the previous month. Females were more likely than males to 
report lifetime use (14% compared to 9%), last year use (5% 
compared to 3%) and current use (3% compared to 1%) of 
sedatives and tranquillisers. Older adults reported higher 
prevalence rates than young adults across each time period.
Ten percent of respondents reported having ever used anti-
depressants, 4% had done so in the previous year, and 3%  
in the previous month. Prevalence rates were broadly similar  
to the corresponding national rates.
Other opiates
Four percent of respondents reported ever using other opiates, 
1% had done so in the previous year, and 0.2% in the previous 
month. Males reported higher lifetime, last year and last month 
prevalence rates than females. Older adults were more likely 
than young adults to report lifetime use (6% compared to 1%), 
last year use (2% compared to 0.4%) and current use (0.5% 
compared to 0%) of other opiates.
Alcohol
Ninety one percent of respondents surveyed in the NRDTF 
reported that they had ever taken alcohol, 88% had done so  
in the previous year, and 78% in the previous month. Recent 
and current prevalence rates were higher across age groups  
and gender than the corresponding national rates. Older adults 
were more likely than young adults to report lifetime use (92% 
compared to 89%) and current use (80% compared to 76%)  
of alcohol. Males reported higher prevalence rates than females 
across the three time periods examined.
Tobacco
Fifty five percent of respondents reported having ever smoked 
tobacco, 37% had done so in the previous year, and 35% in the 
previous month. Across the three time periods prevalence rates 
among males and older adults were higher than the corresponding 
national figures. Conversely, prevalence rates among young 
adults were lower than the corresponding national figures.
NRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
There were increases in lifetime use of cocaine powder (from 
5.0% to 10.7%) and magic mushrooms (from 5.1% to 11.4%) 
among all adults aged 15-64 since the previous survey. Conversely, 
among all adults (15-64) there was a decrease since the previous 
survey, in lifetime use of solvents (from 3.4% to 0.9%).
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Across the age groups, increases were found among those aged 
15-34 years in lifetime use of magic mushrooms (from 6.8% to 
16.3%) since the previous survey. Increases among older adults 
(35-64 years) were found in lifetime use of cocaine powder 
(from 2.6% to 6.4%) and ecstasy (from 1.2% to 4.8%). 
Among males, increases were found in lifetime use of magic 
mushrooms (from 8.2% to 17.0%). Among females there were 
decreases in the lifetime use of tobacco (from 63.1% to 49.8%).
Significant Changes – Last Year Prevalence
Last year use of tobacco among females decreased (from 
44.9% to 33.2%) since the previous survey.
South Eastern Regional Drugs Task Force 
(SERDTF)
(See Tables 14.1, 14.2 and 14.3)
Any illegal drugs
One quarter (25%) of respondents in the South Eastern RDTF 
reported having ever taken any illegal drugs; 8% had done so in 
the previous year, and 4% in the previous month. Lifetime, last 
year and last month prevalence rates among males and young 
adults were higher than the corresponding national rates. Males 
were more likely than females to report lifetime use (32% 
compared to 18%), last year use (11% compared to 4%)  
and last month use (5% compared to 2%) of any illegal drugs. 
Young adults aged 15-34 reported higher prevalence rates  
than older adults aged 35-64 across all time periods.
Cannabis
Cannabis was the most commonly used illegal drug; 23% of 
respondents reported ever taking the drug, 5% had done so in 
the previous year and 3% in the previous month. Young adults 
were at least twice as likely as older adults to report lifetime, last 
year and last month use of cannabis. Males reported higher 
prevalence rates than females across all three time periods.
Other illegal drugs
After cannabis, the highest levels of lifetime use were recorded 
for amphetamines (7%), cocaine powder, magic mushrooms 
and ecstasy (each 6%), poppers (5%), LSD (4%) and solvents 
(3%). By and large, lifetime prevalence rates where higher than 
the corresponding national rates. No heroin or methadone use 
was reported by those surveyed in the SERDTF area.
After cannabis, cocaine powder and ecstasy (each 2%) were  
the most commonly used drugs in the past year followed by 
poppers, amphetamines, and magic mushrooms (each 1%).  
Last month use of cocaine and amphetamines were each 1%, 
ecstasy was 0.3% and LSD was 0.1%.
Sedatives, tranquillisers and anti-depressants
Thirteen percent of respondents reported ever using sedatives 
and tranquillisers, 6% had done so in the previous year and 4% 
in the previous month. Among all adults aged 15-64 in the 
SERDTF, the prevalence rates for sedatives and tranquillisers were 
higher than the corresponding national figures. Females were 
more likely than males to report lifetime use (17% compared to 
10%) and last year use (6% compared to 5%) of sedatives and 
tranquillisers. Older adults reported higher prevalence rates than 
young adults across all time periods.
Ten percent of respondents reported having ever used anti-
depressants, 4% had done so in the previous year, and 2% in the 
previous month. Females lifetime, last year and last month prevalence 
rates for anti-depressants were at least double those of males.
Other opiates
Twelve percent of respondents reported ever using other opiates, 
4% had done so in the previous year, and 3% in the previous 
month. Prevalence rates across age groups and gender were 
substantially higher than the corresponding national figures. Last 
year prevalence rates were higher among females than males 
(5% compared to 4%), but current prevalent rates where higher 
among males than females (3% compared to 2%).
Alcohol
Ninety one percent of respondents surveyed reported that they 
had ever taken alcohol, 83% had done so in the previous year, and 
73% in the previous month. Males reported higher lifetime, last year 
and last month prevalence rates than females. Young adults were 
more likely than older adults to report recent use (88% compared 
to 79%) and current use (76% compared to 70%) of alcohol.
Tobacco
Fifty nine percent of respondents reported having ever smoked 
tobacco, 35% had done so in the previous year, and 32% in the 
previous month. Lifetime, last year and last month prevalence 
rates were lower among older adults and higher among young 
adults than corresponding national figures. Similar proportions of 
males and females reported smoking in their lifetime, in the last 
year and in the last month.
SERDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased among older adults 
(35-64 years) from 11.4% in 2002/3 to 19.1% in 2006/7. 
There was also an increase in lifetime use of any illegal drugs 
among females (from 12.0% to 18.2%).
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There were increases among all adults aged 15-64 in lifetime 
use of cocaine powder (from 2.3% to 6.4%) and solvents  
(from 1.1% to 3.1%) since the previous survey.
Lifetime use of the following drugs increased since the previous 
survey among older adults (35-64 years): cannabis (from 9.8% 
to 16.3%); ecstasy (from 0.2% to 3.2%); LSD (from 1.4% to 
4.4%); and cocaine powder (from 0.8% to 3.6%). Among 
males, increases were found in lifetime use of cocaine powder 
(from 3.1% to 9.5%). There was an increase in lifetime use of 
solvents (from 0.3% to 3.5%) among females.
Significant Changes – Last Month Prevalence
Among all adults aged 15-64, current use of cocaine powder 
increased (from 0.0% to 0.9%) since the previous survey.
South Western Regional Drugs Task Force 
(SWRDTF)
(See Tables 15.1, 15.2 and 15.3)
Any illegal drugs
Just over a quarter (26%) of respondents surveyed in the 
SWRDTF reported having ever taken any illegal drugs; 7% had 
done so in the previous year and 2% in the previous month. 
Recent and current prevalence rates among older adults were 
higher, and lower among young adults, than the corresponding 
national figures.
Cannabis
Cannabis was the most commonly used illegal drug; 24% of 
respondents reported ever taking the drug, 7% had done so in the 
previous year, and 2% in the previous month. Young adults aged 
15-34 were more likely than older adults aged 35-64 to report 
lifetime use (28% compared to 20%) and last year use (9% 
compared to 4%) of cannabis. Males reported higher prevalence 
rates than females across all three time periods examined.
Other illegal drugs
After cannabis, highest levels of lifetime use were recorded for 
magic mushrooms (5%) ecstasy and cocaine powder (each 
4%); amphetamines, solvents, poppers and LSD (each 2%); 
and crack (1%).
After cannabis, last year use was reported as follows: cocaine powder 
(1%), ecstasy (0.5%) and magic mushrooms and methadone 
(each 0.2%). Last month use of cocaine (0.3%) and methadone 
(0.2%) was reported by all adults aged 15-64. The prevalence 
of the former was higher among women (0.6%) than men (0%).
Sedatives, tranquillisers and anti-depressants
Nine percent of respondents reported ever using sedatives and 
tranquillisers, 4% had done so in the previous year and 3% in 
the previous month. Lifetime prevalence rates were lower than 
the corresponding national rates across gender and age groups.
Ten percent of respondents reported having ever used anti-
depressants, 5% had done so in the previous year, and 4% in 
the previous month. Lifetime, last year and last month prevalence 
rates among females and young adults were higher than the 
corresponding national rates. Females lifetime, last year and last 
month prevalence rates for anti-depressants were at least double 
those of males. Similar proportions of young and older adults 
reported recent (5%) and current (4%) anti-depressant use.
Other opiates
Four percent of respondents reported ever using other opiates, 
1% had done so in the previous year, and 1% in the previous 
month. Females were more likely than males to report lifetime use 
(6% compared to 2%) and last year use (2% compared to 1%) 
of other opiates. Similar proportions of young and older adults 
reported lifetime, last year and last month use of other opiates.
Alcohol
Ninety one percent of respondents surveyed reported that they 
had ever taken alcohol, 87% had done so in the previous year, and 
77% in the previous month. Young adults were more likely than 
older adults to report lifetime use (92% compared to 89%) and 
last year use (90% compared to 84%) of alcohol. Males reported 
higher prevalence rates than females across all three time periods.
Tobacco
Fifty six percent of respondents reported having ever smoked 
tobacco, 38% had done so in the previous year, and 34% in the 
previous month. Lifetime, last year and last month prevalence 
rates were higher for women than for men. Young adults were 
more likely than older adults to report recent use of tobacco (44% 
compared to 32%) and current use (36% compared to 31%).
SWRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Among all adults aged 15-64, lifetime use of the following drugs 
decreased since the previous survey: tobacco (from 63.8% to 
56.3%); LSD (from 4.9% to 1.7%); and amphetamines (from 
5.1% to 2.1%)
Across age groups, there were decreases, since the previous 
survey, among young adults (15 -34 years) in the lifetime use  
of amphetamines (from 8.2% to 1.8%) and LSD (from 6.9% to 
1.8%). There were also decreases in lifetime tobacco use among 
those aged 35-64 years, (from 66.0% to 56.2%) and among 
males (from 66.7% to 54.2%). 
In addition, there was a decrease in lifetime use of LSD among 
males (from 7.6% to 2.7%).
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Significant Changes – Last Year Prevalence
Last year use of tobacco decreased from 41.6% in 2002/3  
to 31.9% in 2006/7 among older adults (35-64 years).
There was a decrease in last month use of tobacco among 
males from 42.1% in 2002/3 to 32.4% in 2006/7.
Southern Regional Drugs Task Force (SRDTF)
(See Tables 16.1, 16.2 and 16.3)
Any illegal drugs
Sixteen percent of respondents surveyed in the SRDTF area 
reported having ever taken any illegal drugs; 5% had done so in 
the previous year, and 2% in the previous month. All prevalence 
rates were lower than the corresponding national figures. Males 
were more likely than females to report lifetime use (20% 
compared to 13%), last year use (7% compared to 2%) and 
last month use (4% compared to 0.2%) of any illegal drugs. 
Prevalence rates were higher among young adults than older 
adults, across the three time periods examined.
Cannabis
Cannabis was the most commonly used illegal drug, 15% of 
respondents reported ever taking the drug, 5% had done so  
in the previous year, and 2% in the previous month. Among  
all adults aged 15-64 in the SRDTF, the prevalence rates for 
cannabis were lower than the corresponding national figures.
Other illegal drugs
After cannabis, the highest levels of lifetime use were recorded 
for ecstasy, magic mushrooms, cocaine powder, amphetamine 
and poppers (each 3%), and LSD and solvents (each 1%).
After cannabis, cocaine powder, magic mushrooms and ecstasy 
(each 1%) were the most commonly reported drugs used in the 
past year. Low levels of current ecstasy and cocaine powder use 
(each 0.2%) were reported by those surveyed.
Sedatives, tranquillisers and anti-depressants
Ten percent of respondents reported ever using sedatives and 
tranquillisers, 4% had done so in the previous year and 3% in 
the previous month. Females lifetime, last year and last month 
prevalence rates were lower than the corresponding national 
figures. Older adults were at least three times as likely as young 
adults to report lifetime, recent and current use of sedatives and 
tranquillisers. Similar proportions of males and females reported 
last year (4%) and last month (3%) use.
Seven percent of respondents reported having ever used anti-
depressants, 4% had done so in the previous year, and 3% in 
the previous month. Females lifetime, last year and last month 
prevalence rates were lower than the corresponding national rates.
Other opiates
Five percent of respondents reported ever using other opiates, 
2% had done so in the previous year, and 0.5% in the previous 
month. Females reported higher lifetime, last year and last 
month prevalence rates than males. Older adults were more 
likely than young adults to report lifetime use (7% compared  
to 3%), last year use (3% compared to 0%) and last month  
use (1% compared to 0%) of other opiates.
Alcohol
Eighty seven percent of respondents reported that they had ever 
taken alcohol, 81% had done so in the previous year, and 70% 
in the previous month. Among all adults aged 15-64 in the 
SRDTF, the prevalence rates for alcohol use were lower than the 
corresponding national figures. Lifetime, last year and last month 
prevalence rates were higher among males than females. Older 
adults were more likely than young adults to report current 
alcohol use (71% compared to 69%).
Tobacco
Fifty five percent of respondents reported having ever smoked 
tobacco, 30% had done so in the previous year, and 27% in the 
previous month. Lifetime, last year and last month prevalence 
rates were higher among females than males. Young adults were 
more likely than older adults to report recent use of tobacco (33% 
compared to 28%) and current use (30% compared to 25%).
SRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Lifetime use of any illegal drugs increased from 7.0% in 2002/3  
to 11.6% in 2006/7 among older adults aged 35-64.
Among all adults aged 15-64 there was a decrease in lifetime 
use of alcohol (from 91.2% to 87.2%) since the previous survey. 
Across age groups, increases among older adults (35-64 years) 
were found in lifetime use of poppers (from 0.0% to 1.1%).
Significant Changes – Last Month Prevalence
Among all adults aged 15-64 there was a decrease in last month 
alcohol use (from 75.3% to 69.7%) since the previous survey. 
There were also decreases in last month alcohol use among 
females (from 71.6% to 62.6%) and among those aged 15-35 
(from 78.3% to 68.7%).
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Western Regional Drugs Task Force (WRDTF)
(See Table 17.1, 17.2 and 17.3)
Any illegal drugs
Almost one quarter (23%) of respondents reported having ever 
taken any illegal drugs; 5% had done so in the previous year, 
and 2% in the previous month. Among all adults aged 15-64 in 
the WRDTF, the prevalence rates for use of any illegal drugs were 
lower than the corresponding national figures. Young adults aged 
15-34 were more likely than older adults aged 35-64 to report 
lifetime use (32% compared to 16%), last year use (8% 
compared to 2%) and last month use (3% compared to 0.3%) 
of any illegal drugs. Males reported higher prevalence rates than 
females across all three time periods examined.
Cannabis
Cannabis was the most commonly used illegal drug, 21% of 
respondents reported ever taking the drug, 4% had done so in 
the previous year, and 2% reported recent use. Young adults 
lifetime, last year and last month use prevalence rates for 
cannabis were at least double those of older adults.
Other illegal drugs
After cannabis, highest levels of lifetime use were recorded for 
ecstasy (4%); cocaine powder, magic mushrooms, poppers and 
amphetamines (each 3%); LSD and solvents (each 2%). Last 
year use of cocaine (2%), ecstasy and magic mushrooms (each 
1%), amphetamines (0.4%) and poppers (0.3%) were reported. 
Low levels of current cocaine powder (0.4%) amphetamines 
ecstasy (each 0.3%) and methadone (0.2%) use were reported 
by those surveyed.
Sedatives, tranquillisers and anti-depressants
Ten percent of respondents in the WRDTF reported ever using 
sedatives and tranquillisers, 5% had done so in the previous 
year and 4% in the previous month. Males were more likely than 
females to report lifetime use (10% compared to 9%), last year 
use (6% compared to 3%) and current use (5% compared to 
2%) of sedatives and tranquillisers. Lifetime, last year and last 
month prevalence rates among males were higher than the 
corresponding national rates. Conversely, among females, 
prevalence rates across the three time periods were lower  
than the corresponding national figures.
Ten percent of respondents reported having ever used anti-
depressants, 6% had done so in the previous year, and 5%  
in the previous month. Lifetime, last year and last month 
prevalence rates among males within the WRDTF where higher 
than the corresponding national rates. In addition, current and 
recent prevalence rates among young adults and older adults 
were higher than the corresponding national rates.
Other opiates
Four percent of respondents reported ever using other opiates,  
1% had done so in the previous year, and 0.4% in the previous 
month. Highest prevalence rates for current use were reported 
by young adults and males. Similar proportions of young and 
older adults reported lifetime and last year prevalence rates  
for other opiates
Alcohol
Ninety one percent of respondents surveyed reported that they 
ever taken alcohol, 83% had done so in the previous year,  
and 71% in the previous month. Young adults reported higher 
lifetime, last year and last month use of alcohol than older 
adults. Males were more likely than females to report lifetime 
use (92% compared to 89%), recent use (85% compared  
to 80%) and current use (76% compared to 66%).
Tobacco
Sixty three percent of respondents reported having ever smoked 
tobacco, 38% had done so in the previous year, and 33%  
in the previous month. Young adults reported higher last year 
and current smoking prevalence rates than older adults. Similar 
proportions of males and females reported current use (33% 
compared to 32%) of tobacco.
WRDTF – Results Comparison 2002/-2006/7
All findings reported are statistically significant at least at the  
5% level.
Significant Changes – Lifetime Prevalence
Since the previous survey lifetime use of any illegal drugs 
increased from 12.5% in 2002/3 to 23.3% in 2006/7 among 
all adults (15-64 years). There were also increases in lifetime 
use of any illegal drugs among young adults aged 15-34 (from 
15.6% to 31.7%) and among females (from 8.6% to 17.7%).
Among all adults aged 15-64, lifetime use of cannabis increased 
(from 12.0% to 21.0%) since the previous survey.
Across the age groups, increases were found among young 
adults (15-34 years) in lifetime use of cannabis (from 14.6% to 
29.1%). Among females, there were increases in lifetime use of 
the cannabis (from 8.1% to 15.8%) and cocaine powder (from 
0.9% to 3.5%).
Significant Changes – Last Year Prevalence
Last year use of alcohol increased from 77.1% in 2002/3 to 
82.6% in 2006/7 among all adults aged 15-64. There was an 
increase in last year use of cocaine powder among females (from 
0.0% to 1.9%). Among young adults (15-34 years) there were 
increases, since the previous survey, in last year use of alcohol 
(from 78.2% to 86.4%) and cannabis (from 1.5% to 7.1%).
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Table 1.1 Northern Ireland – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (2002) (893) (1109) (714)* (1280)*
Any illegal drugs1 28.0 33.9 22.1 40.2 19.3
Cannabis 24.7 30.1 19.3 35.0 17.3
Heroin 0.5 0.6 0.4 0.6 0.4
Methadone 0.1 0.1 0.1 0.1 0.1
Other opiates2 20.2 17.4 23.0 14.4 24.7
Cocaine  
(total including crack) 5.2 7.4 2.9 9.1 2.3
Crack 0.4 0.4 0.4 0.6 0.3
Cocaine Powder 5.1 7.3 2.9 9.1 2.2
Amphetamines 5.8 7.3 4.4 9.1 3.4
Ecstasy 7.7 9.9 5.5 14.3 2.9
LSD 6.6 9.7 3.5 9.4 4.5
Magic mushrooms 6.7 11.2 2.4 8.3 5.6
Solvents 3.5 5.1 2.0 5.5 2.1
Poppers3 7.8 10.9 4.9 14.0 3.4
Anabolic Steroids 1.0 0.9 1.0 1.0 0.9
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 20.2 18.1 22.3 11.7 26.5
Anti-depressants 21.0 13.4 28.4 13.6 26.6
Alcohol 87.3 89.4 85.2 87.9 87.2
Tobacco 55.3 59.7 51.1 54.6 56.1
Table 1.2 Northern Ireland – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (2002) (893) (1109) (714)* (1280)*
Any illegal drugs1 9.4 13.7 5.2 17.3 3.7
Cannabis 7.2 10.3 4.1 12.4 3.3
Heroin 0.1 0.0 0.1 0.0 0.1
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 8.4 8.0 8.7 7.1 9.3
Cocaine  
(total including crack) 1.9 2.8 0.9 3.5 0.7
Crack 0.0 0.1 0.0 0.0 0.1
Cocaine Powder 1.9 2.8 0.9 3.5 0.7
Amphetamines 1.0 1.1 0.9 1.7 0.4
Ecstasy 1.8 2.4 1.2 3.4 0.6
LSD 0.2 0.2 0.2 0.0 0.3
Magic mushrooms 0.2 0.1 0.3 0.5 0.0
Solvents 0.2 0.3 0.1 0.4 0.1
Poppers3 1.3 2.3 0.3 2.7 0.2
Anabolic Steroids 0.2 0.2 0.2 0.3 0.2
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 9.2 8.2 10.2 4.6 12.6
Anti-depressants 9.1 5.8 12.4 5.8 11.7
Alcohol 79.0 82.1 75.9 82.0 77.1
Tobacco 33.5 35.9 31.2 39.1 29.5
Table 1.3 Northern Ireland – Last Month Prevalence (%) 
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (2002) (893) (1109) (714)* (1280)*
Any illegal drugs1 3.6 4.9 2.4 5.9 2.0
Cannabis 2.6 3.7 1.6 3.7 1.8
Heroin 0.1 0.0 0.1 0.0 0.1
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 4.9 5.1 4.7 3.6 5.8
Cocaine  
(total including crack) 0.3 0.7 0.0 0.6 0.2
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.3 0.7 0.0 0.6 0.2
Amphetamines 0.3 0.4 0.2 0.3 0.3
Ecstasy 0.8 0.8 0.7 1.4 0.3
LSD 0.0 0.0 0.1 0.0 0.1
Magic mushrooms 0.0 0.1 0.0 0.1 0.0
Solvents 0.1 0.2 0.0 0.2 0.0
Poppers3 0.3 0.6 0.0 0.7 0.0
Anabolic Steroids 0.2 0.2 0.1 0.2 0.1
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 7.1 5.7 8.4 2.3 10.7
Anti-depressants 7.5 4.2 10.7 4.2 10.0
Alcohol 69.5 74.7 64.5 71.0 68.6
Tobacco 29.5 30.9 28.1 32.8 27.1
Prevalence Table 1 – Northern Ireland All HSSB Areas
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
* Eight respondents confirmed they were eligible to participate in the survey but did not state their exact age.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 2 – Northern Ireland Eastern Health and Social Services Board (EHSSB)
Table 2.1 EHSSB – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (462) (205) (257) (162)* (298)*
Any illegal drugs1 36.6 46.5 27.2 54.1 24.1
Cannabis 32.2 40.3 24.5 46.2 22.1
Heroin 0.8 1.3 0.4 0.9 0.8
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 28.0 26.1 29.9 19.9 34.2
Cocaine  
(total including crack) 7.2 10.7 3.8 12.8 3.1
Crack 0.4 0.4 0.4 0.4 0.3
Cocaine Powder 7.2 10.7 3.8 12.8 3.1
Amphetamines 7.3 9.8 4.9 13.1 3.1
Ecstasy 10.5 14.5 6.7 20.0 3.6
LSD 9.5 14.8 4.6 14.9 5.7
Magic mushrooms 10.4 18.0 3.1 13.3 8.4
Solvents 4.7 6.9 2.7 6.4 3.6
Poppers3 9.5 14.0 5.2 18.3 3.1
Anabolic Steroids 1.0 0.9 1.0 1.0 0.9
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 24.0 21.6 26.2 16.3 29.8
Anti-depressants 24.3 15.4 32.8 16.2 30.5
Alcohol 90.1 91.4 88.8 91.4 89.8
Tobacco 58.6 63.3 54.1 56.4 60.6
Table 2.2 EHSSB – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (462) (205) (257) (162)* (298)*
Any illegal drugs1 12.6 18.3 7.3 23.4 4.8
Cannabis 8.7 12.0 5.5 14.4 4.5
Heroin 0.2 0.0 0.4 0.0 0.3
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 10.8 11.3 10.4 9.0 12.2
Cocaine  
(total including crack) 2.8 4.0 1.7 5.6 0.8
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 2.8 4.0 1.7 5.6 0.8
Amphetamines 1.7 1.6 1.7 3.1 0.6
Ecstasy 3.0 4.0 2.1 6.2 0.7
LSD 0.2 0.4 0.0 0.0 0.3
Magic mushrooms 0.3 0.0 0.7 0.8 0.0
Solvents 0.2 0.4 0.0 0.5 0.0
Poppers3 2.3 4.0 0.7 4.9 0.4
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 10.7 10.3 11.1 6.3 14.0
Anti-depressants 9.1 5.0 13.0 3.6 13.3
Alcohol 81.5 85.1 78.0 85.3 79.3
Tobacco 35.1 38.3 32.0 42.3 30.1
Table 2.3 EHSSB – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (462) (205) (257) (162)* (298)*
Any illegal drugs1 5.6 7.4 3.8 8.0 3.9
Cannabis 3.5 5.1 2.1 3.6 3.5
Heroin 0.2 0.0 0.4 0.0 0.3
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 6.3 6.3 6.2 4.2 7.9
Cocaine  
(total including crack) 0.7 1.4 0.0 1.0 0.4
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.7 1.4 0.0 1.0 0.4
Amphetamines 0.4 0.4 0.4 0.4 0.3
Ecstasy 1.6 1.6 1.7 2.9 0.7
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.2 0.4 0.0 0.5 0.0
Poppers3 0.6 1.2 0.0 1.4 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 8.1 6.8 9.4 2.7 12.2
Anti-depressants 8.0 4.1 11.6 2.7 11.8
Alcohol 76.0 81.4 71.0 77.3 75.7
Tobacco 30.3 30.8 29.9 35.1 27.1
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
* Two respondents confirmed they were eligible to participate in the survey but did not state their exact age.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 3 – Northern Ireland Northern Health and Social Services Board (NHSSB)
Table 3.1 NHSSB – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (498) (211) (287) (175)* (322)*
Any illegal drugs1 24.8 28.7 21.0 38.0 15.9
Cannabis 22.2 26.2 18.3 33.8 14.4
Heroin 0.1 0.0 0.3 0.4 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 20.3 14.7 25.8 16.5 22.9
Cocaine  
(total including crack) 3.8 5.6 1.9 6.7 1.8
Crack 0.6 0.0 1.1 1.4 0.0
Cocaine Powder 3.8 5.6 1.9 6.7 1.8
Amphetamines 5.5 6.6 4.4 7.0 4.5
Ecstasy 5.6 6.6 4.6 10.7 2.2
LSD 6.3 8.2 4.4 8.5 4.9
Magic mushrooms 5.6 8.6 2.6 7.1 4.6
Solvents 2.3 3.0 1.7 4.8 0.6
Poppers3 8.1 10.1 6.1 14.8 3.6
Anabolic Steroids 1.0 1.1 1.0 0.9 1.2
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 20.4 19.4 21.4 10.9 27.0
Anti-depressants 20.7 12.9 28.4 13.5 25.7
Alcohol 88.0 90.8 85.1 89.2 87.4
Tobacco 55.1 61.1 49.1 60.2 51.7
Table 3.2 NHSSB – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (498) (211) (287) (175)* (322)*
Any illegal drugs1 7.2 10.2 4.3 13.4 3.0
Cannabis 6.5 9.7 3.4 11.8 3.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 8.4 6.9 9.8 9.0 8.0
Cocaine  
(total including crack) 1.1 2.0 0.3 1.9 0.6
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 1.1 2.0 0.3 1.9 0.6
Amphetamines 0.3 0.4 0.3 0.4 0.3
Ecstasy 0.9 1.5 0.3 1.2 0.6
LSD 0.4 0.4 0.3 0.0 0.6
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.5 0.4 0.6 0.7 0.3
Poppers3 0.6 1.2 0.0 1.5 0.0
Anabolic Steroids 0.5 0.7 0.3 0.9 0.3
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 9.3 8.4 10.1 4.0 12.9
Anti-depressants 8.6 6.2 10.9 7.0 9.7
Alcohol 79.5 82.8 76.2 82.3 77.9
Tobacco 34.7 37.0 32.3 41.3 30.3
Table 3.3 NHSSB – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (498) (211) (287) (175)* (322)*
Any illegal drugs1 1.6 2.0 1.1 2.5 0.9
Cannabis 1.6 2.0 1.1 2.5 0.9
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 5.1 5.2 4.9 5.2 5.0
Cocaine  
(total including crack) 0.0 0.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.0 0.0 0.0 0.0 0.0
Amphetamines 0.2 0.4 0.0 0.0 0.3
Ecstasy 0.0 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.5 0.7 0.3 0.9 0.3
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 7.4 6.1 8.7 1.7 11.3
Anti-depressants 6.8 4.6 8.9 4.0 8.6
Alcohol 66.6 73.0 60.1 68.5 65.5
Tobacco 30.0 32.7 27.3 31.8 28.8
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
* One respondent confirmed they were eligible to participate in the survey but did not state their exact age.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 4 – Northern Ireland Southern Health and Social Services Board (SHSSB)
Table 4.1 SHSSB – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (511) (249) (262) (193)* (316)*
Any illegal drugs1 21.6 25.5 17.8 28.6 16.5
Cannabis 18.7 23.1 14.3 25.6 13.6
Heroin 0.6 0.7 0.4 0.9 0.3
Methadone 0.2 0.4 0.0 0.4 0.0
Other opiates2 10.8 9.9 11.7 8.6 12.5
Cocaine  
(total including crack) 3.5 5.6 1.3 6.3 1.3
Crack 0.6 1.1 0.0 0.4 0.7
Cocaine Powder 3.3 5.2 1.3 6.3 1.0
Amphetamines 3.7 4.7 2.8 4.7 3.0
Ecstasy 5.4 7.2 3.7 10.4 1.6
LSD 2.9 4.3 1.5 3.3 2.6
Magic mushrooms 3.2 5.3 1.1 3.2 3.2
Solvents 3.2 5.4 1.0 5.0 1.9
Poppers3 4.9 8.0 1.8 7.2 3.2
Anabolic Steroids 1.1 1.0 1.3 1.7 0.7
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 15.0 12.0 18.1 8.0 20.1
Anti-depressants 17.8 11.7 23.9 13.2 21.4
Alcohol 80.9 84.4 77.5 81.6 80.6
Tobacco 50.3 54.8 45.9 47.7 52.0
Table 4.2 SHSSB – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (511) (249) (262) (193)* (316)*
Any illegal drugs1 7.4 10.8 4.0 13.7 2.7
Cannabis 7.1 10.2 4.0 13.0 2.7
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 5.7 4.9 6.5 4.9 6.4
Cocaine  
(total including crack) 1.1 2.1 0.0 2.0 0.3
Crack 0.2 0.4 0.0 0.0 0.3
Cocaine Powder 1.1 2.1 0.0 2.0 0.3
Amphetamines 0.7 1.4 0.0 1.1 0.3
Ecstasy 0.8 1.6 0.0 1.8 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.4 0.8 0.0 0.9 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.2 0.4 0.0 0.4 0.0
Anabolic Steroids 0.1 0.0 0.3 0.0 0.2
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 6.8 4.5 9.1 3.4 9.5
Anti-depressants 9.3 5.6 13.0 9.7 9.0
Alcohol 73.6 76.1 71.1 75.3 72.4
Tobacco 29.6 33.3 25.9 36.2 24.4
Table 4.3 SHSSB – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (511) (249) (262) (193)* (316)*
Any illegal drugs1 3.8 5.8 1.8 8.5 0.3
Cannabis 3.5 5.2 1.8 7.8 0.3
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 3.2 3.9 2.5 2.4 3.8
Cocaine  
(total including crack) 0.4 0.8 0.0 0.9 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.4 0.8 0.0 0.9 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.5 1.0 0.0 1.1 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.2 0.4 0.0 0.4 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.2 0.4 0.0 0.4 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 5.2 2.7 7.6 2.6 7.2
Anti-depressants 7.4 3.9 11.0 8.0 7.1
Alcohol 63.2 67.6 58.8 66.0 61.2
Tobacco 26.4 28.3 24.6 32.5 21.6
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
* Two respondents confirmed they were eligible to participate in the survey but did not state their exact age.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 5 – Northern Ireland Western Health and Social Services Board (WHSSB)
Table 5.1 WHSSB – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (531) (228) (303) (184)* (344)*
Any illegal drugs1 20.3 23.7 16.8 25.5 16.5
Cannabis 18.1 21.5 14.6 22.6 14.8
Heroin 0.2 0.0 0.4 0.0 0.4
Methadone 0.2 0.0 0.4 0.0 0.4
Other opiates2 13.2 11.0 15.5 5.8 19.2
Cocaine  
(total including crack) 4.6 5.0 4.2 7.6 2.3
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 4.6 5.0 4.2 7.6 2.3
Amphetamines 5.2 5.6 4.8 8.0 3.0
Ecstasy 7.0 7.6 6.3 11.4 3.6
LSD 4.4 6.6 2.1 5.6 3.5
Magic mushrooms 4.0 6.5 1.5 4.7 3.5
Solvents 3.0 3.8 2.1 5.0 1.4
Poppers3 7.1 8.5 5.7 11.3 3.9
Anabolic Steroids 0.6 0.4 0.8 0.4 0.8
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 17.0 15.1 19.0 6.8 25.1
Anti-depressants 17.5 11.8 23.3 8.3 24.8
Alcohol 87.1 88.8 85.4 85.4 88.6
Tobacco 53.9 55.2 52.6 50.2 57.0
Table 5.2 WHSSB – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (531) (228) (303) (184)* (344)*
Any illegal drugs1 7.6 11.9 3.3 13.3 3.3
Cannabis 4.7 7.5 1.8 8.3 1.9
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 5.7 5.7 5.8 2.8 8.1
Cocaine  
(total including crack) 1.7 2.3 1.2 3.0 0.8
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 1.7 2.3 1.2 3.0 0.8
Amphetamines 0.8 0.7 0.9 1.3 0.4
Ecstasy 1.3 1.0 1.6 2.1 0.8
LSD 0.2 0.0 0.4 0.0 0.4
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 1.2 2.3 0.0 2.4 0.2
Anabolic Steroids 0.3 0.0 0.6 0.4 0.2
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 8.4 7.6 9.2 3.1 12.6
Anti-depressants 9.9 7.1 12.7 4.5 14.1
Alcohol 78.5 81.1 75.7 81.7 76.1
Tobacco 32.6 31.7 33.4 32.3 32.8
Table 5.3 WHSSB – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(unweighted) (531) (228) (303) (184)* (344)*
Any illegal drugs1 2.1 2.8 1.3 3.3 1.2
Cannabis 1.2 1.5 0.9 1.2 1.2
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 3.3 3.4 3.2 1.6 4.8
Cocaine  
(total including crack) 0.0 0.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.0 0.0 0.0 0.0 0.0
Amphetamines 0.5 0.7 0.4 0.8 0.4
Ecstasy 0.2 0.0 0.5 0.5 0.0
LSD 0.2 0.0 0.4 0.0 0.4
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.3 0.7 0.0 0.8 0.0
Anabolic Steroids 0.1 0.0 0.3 0.0 0.2
Nubain® 0.0 0.0 0.0 0.0 0.0
Sedatives & 
Tranquillisers 6.5 6.2 6.8 1.8 10.3
Anti-depressants 7.7 4.4 11.1 3.2 11.3
Alcohol 66.1 70.1 61.9 66.4 65.8
Tobacco 30.2 31.3 29.0 29.3 30.8
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
* Three respondents confirmed they were eligible to participate in the survey but did not state their exact age.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 6 – Northern Ireland Overview All Adults 15-64 All HSSB Areas
Table 6.1 Northern Ireland – Lifetime Prevalence (%)
Drug
EHSSB NHSSB SHSSB WHSSB
02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7
Total Sample 
(unweighted) (1393) (462) (877) (498) (655) (511) (591) (531)
Any illegal 
drugs1 22.5 36.6 17.8 24.8 19.1 21.6 18.7 20.3
Cannabis 18.9 32.2 14.4 22.2 16.3 18.7 16.3 18.1
Heroin 0.1 0.8 0.4 0.1 0.0 0.6 0.4 0.2
Methadone 0.2 0.0 0.0 0.0 0.2 0.2 0.2 0.2
Cocaine (total 
including crack) 2.4 7.2 1.0 3.8 0.8 3.5 1.6 4.6
Crack 0.1 0.4 0.3 0.6 0.0 0.6 0.9 0.0
Cocaine 
Powder 2.3 7.2 1.0 3.8 0.8 3.3 1.5 4.6
Amphetamines 4.9 7.3 4.1 5.5 2.3 3.7 3.8 5.2
Ecstasy 7.1 10.5 5.9 5.6 3.2 5.4 5.2 7.0
LSD 5.1 9.5 4.7 6.3 3.4 2.9 4.1 4.4
Magic 
mushrooms 4.3 10.4 5.2 5.6 2.9 3.2 4.7 4.0
Solvents 2.4 4.7 2.9 2.3 3.2 3.2 3.7 3.0
Poppers2 6.3 9.5 6.7 8.1 3.4 4.9 4.3 7.1
Anabolic 
Steroids 0.8 1.0 0.2 1.0 0.4 1.1 1.6 0.6
Nubain® 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0
Alcohol 90.9 90.1 86.1 88.0 85.7 80.9 87.4 87.1
Tobacco 59.5 58.6 54.9 55.1 57.3 50.3 63.4 53.9
n  cell indicates a significant increase from 2002/3 to 2006/7.
n  cell indicates a significant decrease from 2002/3 to 2006/7.
Table 6.2 Northern Ireland – Last Year Prevalence (%)
Drug
EHSSB NHSSB SHSSB WHSSB
02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7
Total Sample 
(unweighted) (1393) (462) (877) (498) (655) (511) (591) (531)
Any illegal 
drugs1 7.3 12.6 6.2 7.2 5.1 7.4 5.8 7.6
Cannabis 6.0 8.7 5.4 6.5 4.3 7.1 5.3 4.7
Heroin 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0
Cocaine (total 
including crack) 1.0 2.8 0.0 1.1 0.2 1.1 0.4 1.7
Crack 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0
Cocaine 
Powder 1.0 2.8 0.0 1.1 0.2 1.1 0.2 1.7
Amphetamines 1.5 1.7 0.6 0.3 0.0 0.7 0.4 0.8
Ecstasy 2.3 3.0 1.5 0.9 0.5 0.8 1.4 1.3
LSD 0.1 0.2 0.0 0.4 0.2 0.0 0.0 0.2
Magic 
mushrooms 0.2 0.3 0.3 0.0 0.4 0.4 0.0 0.0
Solvents 0.3 0.2 0.0 0.5 0.2 0.0 0.2 0.0
Poppers2 0.6 2.3 0.6 0.6 0.4 0.2 0.2 1.2
Anabolic 
Steroids 0.3 0.0 0.0 0.5 0.3 0.1 0.9 0.3
Nubain® 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Alcohol 82.4 81.5 77.1 79.5 76.5 73.6 78.4 78.5
Tobacco 40.3 35.1 38.3 34.7 38.6 29.6 44.7 32.6
n  cell indicates a significant increase from 2002/3 to 2006/7.
n  cell indicates a significant decrease from 2002/3 to 2006/7.
Table 6.3 Northern Ireland – Last Month Prevalence (%)
Drug
EHSSB NHSSB SHSSB WHSSB
02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7
Total Sample 
(unweighted) (1393) (462) (877) (498) (655) (511) (591) (531)
Any illegal 
drugs1 3.8 5.6 3.8 1.6 2.1 3.8 3.0 2.1
Cannabis 3.4 3.5 3.5 1.6 1.5 3.5 2.6 1.2
Heroin 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0
Cocaine (total 
including crack) 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.0
Crack 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine 
Powder 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.0
Amphetamines 0.4 0.4 0.2 0.2 0.0 0.0 0.2 0.5
Ecstasy 0.5 1.6 1.1 0.0 0.2 0.5 0.0 0.2
LSD 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2
Magic 
mushrooms 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0
Solvents 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.0
Poppers2 0.2 0.6 0.1 0.0 0.2 0.2 0.0 0.3
Anabolic 
Steroids 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.1
Nubain® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Alcohol 71.9 76.0 64.5 66.6 64.5 63.2 65.3 66.1
Tobacco 37.4 30.3 35.4 30.0 35.2 26.4 40.7 30.2
n  cell indicates a significant increase from 2002/3 to 2006/7.
n  cell indicates a significant decrease from 2002/3 to 2006/7.
1 For this study “any illegal drug” refers to the use of amphetamine, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 Poppers i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 7 – Ireland All RDTF Areas
Table 7.1 Ireland – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (4967) (2027) (2940) (1989) (2978)
Any illegal drugs1 24.0 29.4 18.5 31.4 17.6
Cannabis 21.9 27.0 16.6 28.6 16.1
Heroin 0.4 0.5 0.4 0.4 0.4
Methadone 0.3 0.3 0.3 0.5 0.2
Other opiates2 6.2 4.7 7.8 4.6 7.6
Cocaine  
(total including crack) 5.3 7.0 3.5 8.2 2.7
Crack 0.6 0.8 0.4 1.0 0.2
Cocaine Powder 5.0 6.7 3.3 7.8 2.6
Amphetamines 3.5 4.6 2.5 5.1 2.1
Ecstasy 5.4 7.2 3.6 9.0 2.3
LSD 2.9 4.0 1.7 3.6 2.2
Magic mushrooms 5.8 7.7 3.8 8.4 3.5
Solvents 1.9 2.3 1.4 3.2 0.8
Poppers3 3.3 4.2 2.4 5.5 1.4
Anabolic Steroids 0.7 0.7 0.6 0.5 0.8
Sedatives & 
tranquillisers 10.5 8.0 13.2 5.9 14.6
Anti-depressants 9.2 5.9 12.5 7.1 11.0
Alcohol 90.3 91.8 88.8 90.5 90.1
Tobacco 57.9 59.0 56.8 56.3 59.4
Table 7.2 Ireland–Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (4967) (2027) (2940) (1989) (2978)
Any illegal drugs1 7.2 9.6 4.7 12.1 2.9
Cannabis 6.3 8.5 3.9 10.4 2.6
Heroin 0.1 0.1 0.1 0.1 0.1
Methadone 0.1 0.1 0.2 0.2 0.1
Other opiates2 2.1 1.5 2.8 1.8 2.5
Cocaine  
(total including crack) 1.7 2.3 1.0 3.1 0.5
Crack 0.1 0.1 0.1 0.2 0.0
Cocaine Powder 1.6 2.2 0.9 2.9 0.5
Amphetamines 0.4 0.5 0.3 0.8 0.1
Ecstasy 1.2 1.8 0.6 2.4 0.2
LSD 0.2 0.2 0.1 0.4 0.0
Magic mushrooms 0.6 0.9 0.4 1.2 0.2
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.5 0.6 0.3 0.9 0.1
Anabolic Steroids 0.3 0.3 0.3 0.3 0.3
Sedatives & 
tranquillisers 4.7 3.7 5.7 2.6 6.5
Anti-depressants 4.3 3.0 5.6 3.2 5.2
Alcohol 84.2 86.4 81.8 86.5 82.1
Tobacco 36.3 36.8 35.8 40.8 32.3
Table 7.3 Ireland – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (4967) (2027) (2940) (1989) (2978)
Any illegal drug1 2.9 4.3 1.4 4.8 1.2
Cannabis 2.6 4.0 1.1 4.2 1.2
Heroin 0.0 0.0 0.1 0.0 0.1
Methadone 0.1 0.1 0.2 0.1 0.1
Other opiates2 1.0 0.9 1.1 0.8 1.1
Cocaine  
(total including crack) 0.5 0.8 0.2 1.0 0.0
Crack 0.0 0.0 0.0 0.1 0.0
Cocaine Powder 0.5 0.7 0.2 1.0 0.0
Amphetamines 0.1 0.1 0.1 0.2 0.0
Ecstasy 0.3 0.5 0.2 0.6 0.1
LSD 0.0 0.1 0.0 0.1 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.1 0.1 0.1 0.1 0.0
Anabolic Steroids 0.1 0.1 0.1 0.2 0.1
Sedatives & 
tranquillisers 3.0 2.4 3.5 1.3 4.4
Anti-depressants 3.1 2.3 3.9 2.2 3.9
Alcohol 73.4 78.2 68.4 73.8 73.0
Tobacco 32.6 33.6 31.6 36.0 29.7
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 8 – Ireland East Coast RDTF (ECRDTF)
Table 8.1 ECRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (360) (139) (221) (150) (210)
Any illegal drugs1 38.4 45.4 31.9 42.5 34.4
Cannabis 35.9 42.9 29.5 38.1 33.7
Heroin 0.3 0.6 0.0 0.0 0.6
Methadone 0.8 1.6 0.0 1.6 0.0
Other opiates2 12.8 6.7 18.4 10.7 14.8
Cocaine  
(total including crack) 9.1 11.4 6.9 11.0 7.2
Crack 0.9 1.4 0.5 1.2 0.6
Cocaine Powder 9.1 11.4 6.9 11.0 7.2
Amphetamines 3.9 4.8 3.2 4.2 3.7
Ecstasy 7.6 11.0 4.5 10.5 4.8
LSD 4.1 4.1 4.1 4.5 3.7
Magic mushrooms 10.5 10.8 10.3 13.9 7.3
Solvents 2.1 1.6 2.6 3.3 1.0
Poppers3 5.4 6.9 4.1 7.7 3.2
Anabolic Steroids 1.7 3.2 0.3 2.5 0.9
Sedatives & 
tranquillisers 12.3 7.1 17.2 8.3 16.2
Anti-depressants 7.8 4.6 10.9 5.3 10.3
Alcohol 92.8 95.2 90.6 91.1 94.5
Tobacco 59.8 61.2 58.5 56.0 63.6
Table 8.2 ECRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (360) (139) (221) (150) (210)
Any illegal drugs1 12.4 13.8 11.1 17.9 7.0
Cannabis 11.3 13.8 9.0 16.2 6.5
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 4.6 0.7 8.2 3.8 5.3
Cocaine  
(total including crack) 3.1 3.7 2.6 4.6 1.6
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 3.1 3.7 2.6 4.6 1.6
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 2.3 4.9 0.0 4.1 0.6
LSD 0.2 0.0 0.5 0.5 0.0
Magic mushrooms 2.0 2.3 1.8 3.0 1.1
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.3 0.0 0.7 0.7 0.0
Anabolic Steroids 0.6 0.9 0.3 0.9 0.3
Sedatives & 
tranquillisers 5.3 3.6 6.8 3.1 7.4
Anti-depressants 3.6 2.5 4.6 1.5 5.7
Alcohol 86.1 87.2 85.1 87.8 84.4
Tobacco 38.7 41.3 36.3 44.5 33.1
Table 8.3 ECRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (360) (139) (221) (150) (210)
Any illegal drugs1 5.3 7.2 3.7 7.8 2.9
Cannabis 4.2 5.5 3.0 5.5 2.9
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 1.9 0.7 3.0 1.7 2.2
Cocaine  
(total including crack) 0.8 1.6 0.0 1.6 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.8 1.6 0.0 1.6 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.5 0.9 0.0 0.9 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.3 0.0 0.7 0.7 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 2.3 0.7 3.8 0.5 4.0
Anti-depressants 2.9 1.9 3.8 1.5 4.3
Alcohol 77.2 79.8 74.9 78.4 76.1
Tobacco 32.4 35.5 29.5 37.2 27.7
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 9 – Ireland Midland RDTF (MRDTF)
Table 9.1 MRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (401) (160) (241) (164) (237)
Any illegal drugs1 19.6 23.9 14.9 27.7 12.9
Cannabis 17.0 19.7 14.1 23.6 11.6
Heroin 0.2 0.0 0.4 0.0 0.4
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 5.1 1.7 8.8 1.8 7.8
Cocaine  
(total including crack) 4.4 5.2 3.5 6.7 2.4
Crack 0.3 0.7 0.0 0.7 0.0
Cocaine Powder 4.0 4.5 3.5 6.0 2.4
Amphetamines 3.6 4.9 2.1 4.7 2.7
Ecstasy 5.8 8.7 2.7 10.5 2.0
LSD 2.4 3.7 1.1 3.3 1.8
Magic mushrooms 5.5 9.6 1.1 10.5 1.4
Solvents 2.7 3.7 1.6 3.7 1.9
Poppers3 2.6 2.7 2.5 4.2 1.4
Anabolic Steroids 0.6 0.5 0.8 0.0 1.2
Sedatives & 
tranquillisers 12.1 9.2 15.3 4.2 18.6
Anti-depressants 10.0 6.6 13.7 6.5 13.0
Alcohol 90.9 91.0 90.8 89.8 91.8
Tobacco 60.2 60.6 59.8 63.3 57.6
Table 9.2 MRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (401) (160) (241) (164) (237)
Any illegal drugs1 4.4 6.0 2.7 9.2 0.5
Cannabis 4.1 5.4 2.7 8.5 0.5
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 1.3 1.2 1.5 0.4 2.1
Cocaine  
(total including crack) 1.7 1.4 1.9 3.7 0.0
Crack 0.3 0.7 0.0 0.7 0.0
Cocaine Powder 1.3 0.8 1.9 3.0 0.0
Amphetamines 0.2 0.0 0.4 0.4 0.0
Ecstasy 0.9 0.8 1.0 1.9 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.3 0.7 0.0 0.7 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.2 0.0 0.4 0.0 0.3
Sedatives & 
tranquillisers 5.1 2.0 8.4 1.4 8.1
Anti-depressants 3.3 0.7 6.0 3.5 3.0
Alcohol 83.5 85.9 81.0 86.0 81.4
Tobacco 39.5 37.5 41.5 46.6 33.7
Table 9.3 MRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (401) (160) (241) (164) (237)
Any illegal drugs1 1.7 2.1 1.3 3.8 0.0
Cannabis 1.1 1.4 0.7 2.4 0.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 0.7 0.7 0.8 0.0 1.3
Cocaine  
(total including crack) 0.9 1.4 0.4 2.0 0.0
Crack 0.3 0.7 0.0 0.7 0.0
Cocaine Powder 0.6 0.8 0.4 1.3 0.0
Amphetamines 0.2 0.0 0.4 0.4 0.0
Ecstasy 0.3 0.0 0.6 0.7 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 3.1 1.3 5.1 0.0 5.7
Anti-depressants 2.6 0.7 4.7 2.1 3.0
Alcohol 70.3 73.8 66.6 71.2 69.5
Tobacco 36.2 35.9 36.4 42.0 31.4
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 10 – Ireland Mid-Western RDTF (MWRDTF)
Table 10.1 MWRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (537) (214) (323) (208) (329)
Any illegal drugs1 18.0 21.6 14.2 26.0 11.4
Cannabis 17.0 20.6 13.3 24.6 10.8
Heroin 0.3 0.6 0.0 0.7 0.0
Methadone 0.3 0.6 0.0 0.7 0.0
Other opiates2 6.1 3.9 8.4 6.0 6.2
Cocaine  
(total including crack) 2.9 4.2 1.6 4.9 1.4
Crack 0.6 1.2 0.0 1.4 0.0
Cocaine Powder 2.9 4.2 1.6 4.9 1.4
Amphetamines 2.6 3.6 1.6 4.6 1.0
Ecstasy 2.9 3.8 2.0 6.0 0.4
LSD 2.3 3.6 1.0 4.2 0.7
Magic mushrooms 3.1 4.4 1.7 4.4 1.9
Solvents 2.2 3.0 1.3 4.4 0.4
Poppers3 1.8 2.2 1.5 3.7 0.2
Anabolic Steroids 0.4 0.5 0.3 0.0 0.7
Sedatives & 
tranquillisers 8.8 5.2 12.6 5.3 11.7
Anti-depressants 10.0 5.6 14.6 9.0 10.8
Alcohol 90.0 92.7 87.2 90.9 89.3
Tobacco 60.0 63.5 56.2 57.7 61.8
Table 10.2 MWRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (537) (214) (323) (208) (329)
Any illegal drugs1 5.8 7.9 3.5 11.3 1.2
Cannabis 4.7 6.6 2.8 9.2 1.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 3.1 2.3 4.0 5.4 1.2
Cocaine  
(total including crack) 1.0 1.6 0.3 2.2 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 1.0 1.6 0.3 2.2 0.0
Amphetamines 0.7 1.0 0.3 1.5 0.0
Ecstasy 0.8 1.6 0.0 1.8 0.0
LSD 0.3 0.6 0.0 0.7 0.0
Magic mushrooms 0.4 0.6 0.3 0.7 0.2
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 1.3 1.4 1.1 2.5 0.2
Anabolic Steroids 0.1 0.0 0.3 0.0 0.3
Sedatives & 
tranquillisers 4.3 2.9 5.7 2.8 5.5
Anti-depressants 4.3 3.5 5.2 2.7 5.6
Alcohol 82.7 85.4 79.9 86.0 79.9
Tobacco 38.9 39.4 38.4 40.4 37.7
Table 10.3 MWRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (537) (214) (323) (208) (329)
Any illegal drugs1 1.4 2.8 0.0 2.7 0.4
Cannabis 1.4 2.8 0.0 2.7 0.4
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 1.3 1.4 1.1 2.5 0.2
Cocaine  
(total including crack) 0.0 0.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.0 0.0 0.0 0.0 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.3 0.6 0.0 0.7 0.0
LSD 0.3 0.6 0.0 0.7 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 2.0 2.0 2.1 0.5 3.3
Anti-depressants 2.5 1.8 3.2 1.5 3.3
Alcohol 72.2 76.2 67.9 73.8 70.8
Tobacco 35.9 36.5 35.2 37.9 34.1
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 11 – Ireland North Eastern RDTF (NERDTF)
Table 11.1 NERDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (446) (171) (275) (170) (276)
Any illegal drugs1 22.9 29.4 16.1 29.2 17.6
Cannabis 19.5 25.2 13.4 25.0 14.9
Heroin 0.5 0.7 0.3 0.8 0.3
Methadone 0.5 0.7 0.3 0.8 0.3
Other opiates2 4.2 3.4 5.0 4.8 3.6
Cocaine  
(total including crack) 5.6 8.1 3.0 10.2 1.8
Crack 1.4 2.0 0.7 3.0 0.0
Cocaine Powder 4.9 7.4 2.3 8.7 1.8
Amphetamines 3.3 4.2 2.3 5.8 1.1
Ecstasy 5.4 6.8 3.9 9.8 1.7
LSD 3.0 4.9 1.0 3.9 2.2
Magic mushrooms 5.0 7.8 2.0 8.3 2.2
Solvents 2.0 3.2 0.7 3.5 0.8
Poppers3 3.1 3.8 2.3 5.1 1.4
Anabolic Steroids 1.9 2.5 1.3 1.6 2.2
Sedatives & 
tranquillisers 9.9 6.5 13.5 3.4 15.4
Anti-depressants 8.4 4.6 12.3 3.3 12.6
Alcohol 90.6 90.6 90.7 89.1 91.9
Tobacco 58.1 62.1 53.8 57.3 58.7
Table 11.2 NERDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (446) (171) (275) (170) (276)
Any illegal drugs1 5.7 8.3 3.0 9.4 2.6
Cannabis 4.6 6.4 2.6 7.8 1.9
Heroin 0.1 0.0 0.3 0.0 0.3
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 0.9 0.0 1.9 1.1 0.8
Cocaine  
(total including crack) 1.5 2.8 0.0 3.2 0.0
Crack 0.3 0.7 0.0 0.8 0.0
Cocaine Powder 1.1 2.2 0.0 2.4 0.0
Amphetamines 0.5 0.7 0.3 0.8 0.3
Ecstasy 0.9 1.5 0.3 1.7 0.3
LSD 0.4 0.7 0.0 0.8 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.2 0.0 0.4 0.0 0.3
Poppers3 0.6 1.2 0.0 0.8 0.4
Anabolic Steroids 1.4 2.0 0.7 1.6 1.2
Sedatives & 
tranquillisers 5.0 2.7 7.5 1.9 7.6
Anti-depressants 3.7 1.9 5.6 0.7 6.2
Alcohol 84.4 85.0 83.7 84.7 84.1
Tobacco 37.2 43.2 31.0 43.9 31.6
Table 11.3 NERDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (446) (171) (275) (170) (276)
Any illegal drugs1 1.1 1.8 0.3 1.5 0.7
Cannabis 0.8 1.3 0.3 1.5 0.3
Heroin 0.1 0.0 0.3 0.0 0.3
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 0.3 0.0 0.6 0.0 0.5
Cocaine  
(total including crack) 0.0 0.0 0.0 0.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.0 0.0 0.0 0.0 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.2 0.5 0.0 0.0 0.4
Anabolic Steroids 0.9 1.4 0.4 1.6 0.3
Sedatives & 
tranquillisers 2.9 1.7 4.2 0.8 4.6
Anti-depressants 2.4 1.0 3.9 0.7 3.8
Alcohol 73.2 79.8 66.2 72.2 74.0
Tobacco 35.1 41.6 28.3 41.0 30.2
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 12 – Ireland North Western RDTF (NWRDTF)
Table 12.1 NWRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (386) (170) (216) (145) (241)
Any illegal drugs1 14.5 17.5 11.4 21.1 9.5
Cannabis 12.8 16.8 8.7 18.9 8.2
Heroin 0.7 0.8 0.5 1.0 0.4
Methadone 0.3 0.0 0.5 0.0 0.4
Other opiates2 8.0 7.1 9.0 4.8 10.4
Cocaine  
(total including crack) 1.6 1.6 1.7 3.2 0.4
Crack 1.4 1.6 1.1 2.6 0.4
Cocaine Powder 1.6 1.6 1.7 3.2 0.4
Amphetamines 2.1 3.1 1.1 2.6 1.8
Ecstasy 2.2 2.9 1.5 4.7 0.4
LSD 1.3 2.1 0.5 1.9 0.9
Magic mushrooms 3.0 3.9 2.1 3.5 2.6
Solvents 2.0 2.4 1.7 4.1 0.4
Poppers3 2.6 3.6 1.5 5.5 0.4
Anabolic Steroids 1.2 0.0 2.3 0.0 2.0
Sedatives & 
tranquillisers 11.8 9.3 14.3 5.3 16.6
Anti-depressants 9.9 7.2 12.7 7.1 12.0
Alcohol 90.1 90.0 90.2 89.2 90.8
Tobacco 56.2 58.2 54.1 54.7 57.2
Table 12.2 NWRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (386) (170) (216) (145) (241)
Any illegal drugs1 2.9 3.9 2.0 6.8 0.0
Cannabis 2.9 3.9 2.0 6.8 0.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 2.6 2.5 2.6 1.6 3.3
Cocaine  
(total including crack) 0.3 0.0 0.6 0.7 0.0
Crack 0.3 0.0 0.6 0.7 0.0
Cocaine Powder 0.3 0.0 0.6 0.7 0.0
Amphetamines 0.3 0.0 0.6 0.7 0.0
Ecstasy 0.3 0.0 0.6 0.7 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.3 0.0 0.6 0.7 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.3 0.0 0.6 0.7 0.0
Anabolic Steroids 0.4 0.0 0.8 0.0 0.7
Sedatives & 
tranquillisers 6.0 5.8 6.3 3.0 8.3
Anti-depressants 5.3 4.2 6.4 4.1 6.2
Alcohol 78.6 80.0 77.2 80.4 77.3
Tobacco 32.3 34.9 29.6 39.7 26.8
Table 12.3 NWRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (386) (170) (216) (145) (241)
Any illegal drugs1 0.3 0.0 0.6 0.7 0.0
Cannabis 0.3 0.0 0.6 0.7 0.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 0.4 0.5 0.4 0.0 0.8
Cocaine  
(total including crack) 0.3 0.0 0.6 0.7 0.0
Crack 0.3 0.0 0.6 0.7 0.0
Cocaine Powder 0.3 0.0 0.6 0.7 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.3 0.0 0.6 0.7 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.4 0.0 0.8 0.0 0.7
Sedatives & 
tranquillisers 4.5 3.5 5.5 1.6 6.6
Anti-depressants 3.6 3.7 3.5 1.8 4.9
Alcohol 64.9 68.9 60.7 70.5 60.7
Tobacco 28.0 30.1 25.9 34.9 22.9
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 13 – Ireland Northern Area RDTF (NRDTF)
Table 13.1 NRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (483) (198) (285) (198) (285)
Any illegal drugs1 32.2 40.1 24.3 44.3 21.2
Cannabis 28.8 37.0 20.7 40.3 18.4
Heroin 1.5 1.4 1.5 1.3 1.6
Methadone 1.0 0.4 1.5 0.8 1.1
Other opiates2 3.9 4.7 3.0 1.4 6.1
Cocaine  
(total including crack) 11.0 15.1 6.9 15.9 6.4
Crack 0.5 0.5 0.5 0.5 0.5
Cocaine Powder 10.7 15.1 6.4 15.4 6.4
Amphetamines 5.5 7.1 4.0 8.1 3.2
Ecstasy 11.2 16.6 5.9 18.2 4.8
LSD 6.3 9.3 3.3 8.1 4.6
Magic mushrooms 11.4 17.0 5.9 16.3 6.9
Solvents 0.9 0.5 1.4 1.5 0.5
Poppers3 5.7 7.9 3.5 8.6 3.1
Anabolic Steroids 0.2 0.0 0.4 0.0 0.3
Sedatives & 
tranquillisers 11.3 8.6 14.0 6.6 15.6
Anti-depressants 9.6 5.3 13.9 7.7 11.3
Alcohol 91.0 93.7 88.2 89.4 92.4
Tobacco 55.4 61.1 49.8 49.6 60.7
Table 13.2 NRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (483) (198) (285) (198) (285)
Any illegal drugs1 12.8 17.6 8.0 20.8 5.5
Cannabis 11.9 17.6 6.3 18.9 5.5
Heroin 0.4 0.5 0.3 0.5 0.2
Methadone 0.7 0.0 1.5 0.8 0.7
Other opiates2 1.2 1.4 0.9 0.4 1.9
Cocaine  
(total including crack) 3.3 5.8 0.8 5.6 1.1
Crack 0.3 0.0 0.5 0.5 0.0
Cocaine Powder 3.0 5.8 0.3 5.1 1.1
Amphetamines 1.1 1.7 0.6 2.1 0.2
Ecstasy 2.9 4.7 1.1 5.3 0.7
LSD 0.3 0.5 0.0 0.5 0.0
Magic mushrooms 1.1 1.9 0.4 2.3 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 1.0 1.0 1.0 2.1 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 4.1 3.3 4.9 3.1 4.9
Anti-depressants 3.8 2.3 5.3 3.3 4.3
Alcohol 87.9 91.9 84.0 87.5 88.3
Tobacco 37.2 41.2 33.2 36.0 38.2
Table 13.3 NRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (483) (198) (285) (198) (285)
Any illegal drugs1 8.2 13.2 3.3 13.7 3.2
Cannabis 7.9 12.5 3.3 13.0 3.2
Heroin 0.1 0.0 0.3 0.0 0.2
Methadone 0.7 0.0 1.5 0.8 0.7
Other opiates2 0.2 0.5 0.0 0.0 0.5
Cocaine  
(total including crack) 1.4 2.8 0.0 2.5 0.4
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 1.4 2.8 0.0 2.5 0.4
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 1.0 1.8 0.3 1.4 0.7
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.3 0.5 0.0 0.5 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 2.3 1.4 3.3 1.3 3.3
Anti-depressants 3.0 2.3 3.7 1.8 4.1
Alcohol 78.3 85.3 71.3 76.4 79.9
Tobacco 34.8 38.1 31.6 33.3 36.2
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 14 – Ireland South Eastern RDTF (SERDTF)
Table 14.1 SERDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (440) (169) (271) (184) (256)
Any illegal drugs1 25.4 32.4 18.2 33.7 19.1
Cannabis 23.3 29.7 16.6 32.3 16.3
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 11.9 11.9 11.8 8.5 14.5
Cocaine  
(total including crack) 6.7 10.1 3.3 10.1 4.1
Crack 0.5 0.6 0.5 0.5 0.5
Cocaine Powder 6.4 9.5 3.3 10.1 3.6
Amphetamines 6.9 8.0 5.7 10.8 3.9
Ecstasy 6.5 8.7 4.2 10.7 3.2
LSD 4.1 6.0 2.2 3.8 4.4
Magic mushrooms 6.3 8.9 3.6 7.8 5.1
Solvents 3.1 2.7 3.5 5.7 1.0
Poppers3 4.5 6.4 2.5 7.6 2.1
Anabolic Steroids 0.4 0.4 0.4 0.0 0.7
Sedatives & 
tranquillisers 13.3 9.8 16.9 6.6 18.5
Anti-depressants 10.3 6.9 13.9 8.8 11.5
Alcohol 90.5 91.3 89.6 91.1 90.1
Tobacco 59.3 60.2 58.5 61.2 57.9
Table 14.2 SERDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (440) (169) (271) (184) (256)
Any illegal drugs1 7.9 11.1 4.5 14.9 2.4
Cannabis 5.1 7.4 2.6 9.8 1.4
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 4.4 3.9 4.9 3.4 5.1
Cocaine  
(total including crack) 2.4 3.4 1.4 4.2 1.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 2.4 3.4 1.4 4.2 1.0
Amphetamines 0.6 0.7 0.5 1.3 0.0
Ecstasy 1.9 2.9 0.9 4.4 0.0
LSD 0.1 0.0 0.3 0.3 0.0
Magic mushrooms 0.6 0.6 0.7 0.8 0.5
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.8 1.6 0.0 1.8 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 5.6 5.0 6.3 3.3 7.4
Anti-depressants 3.9 2.3 5.5 2.5 4.9
Alcohol 83.2 84.6 81.8 88.1 79.4
Tobacco 35.0 34.9 35.1 44.7 27.5
Table 14.3 SERDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (440) (169) (271) (184) (256)
Any illegal drugs1 3.6 5.0 2.2 6.8 1.0
Cannabis 2.8 4.3 1.2 5.0 1.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 2.8 3.3 2.4 2.0 3.4
Cocaine  
(total including crack) 0.9 1.3 0.5 2.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.9 1.3 0.5 2.0 0.0
Amphetamines 0.6 0.7 0.5 1.3 0.0
Ecstasy 0.3 0.7 0.0 0.8 0.0
LSD 0.1 0.0 0.3 0.3 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 4.1 4.0 4.2 1.8 5.9
Anti-depressants 2.4 1.4 3.6 0.8 3.7
Alcohol 72.6 76.9 68.1 75.8 70.1
Tobacco 31.6 32.3 31.0 39.2 25.8
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 15 – Ireland South Western RDTF (SWRDTF)
Table 15.1 SWRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (689) (290) (399) (315) (374)
Any illegal drugs1 25.6 31.3 19.7 30.9 19.9
Cannabis 24.0 29.6 18.2 28.1 19.5
Heroin 0.4 0.6 0.3 0.2 0.7
Methadone 0.3 0.3 0.3 0.2 0.3
Other opiates2 4.1 1.7 6.5 3.8 4.3
Cocaine  
(total including crack) 3.8 4.7 3.0 6.2 1.4
Crack 0.6 0.8 0.4 0.8 0.3
Cocaine Powder 3.6 4.2 3.0 5.7 1.4
Amphetamines 2.1 2.9 1.2 1.8 2.3
Ecstasy 4.1 4.5 3.6 6.0 2.0
LSD 1.7 2.7 0.8 1.8 1.6
Magic mushrooms 5.4 6.7 4.1 7.3 3.4
Solvents 1.9 2.6 1.2 3.1 0.7
Poppers3 1.9 1.8 1.9 3.1 0.5
Anabolic Steroids 0.3 0.3 0.4 0.0 0.7
Sedatives & 
tranquillisers 8.8 6.5 11.2 6.8 11.0
Anti-depressants 9.8 5.3 14.5 8.9 10.8
Alcohol 90.9 92.9 88.9 92.5 89.2
Tobacco 56.3 54.2 58.5 56.4 56.2
Table 15.2 SWRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (689) (290) (399) (315) (374)
Any illegal drugs1 7.4 10.0 4.6 10.1 4.4
Cannabis 6.7 8.9 4.4 8.8 4.4
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.2 0.3 0.0 0.0 0.3
Other opiates2 1.4 1.1 1.8 1.5 1.4
Cocaine  
(total including crack) 0.8 1.0 0.6 1.3 0.3
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.8 1.0 0.6 1.3 0.3
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.5 0.0 1.0 1.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.2 0.5 0.0 0.4 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.1 0.0 0.2 0.0 0.2
Sedatives & 
tranquillisers 3.9 2.3 5.6 2.5 5.4
Anti-depressants 5.2 2.3 8.1 5.3 5.1
Alcohol 87.1 89.3 84.9 90.3 83.8
Tobacco 37.9 37.1 38.8 43.6 31.9
Table 15.3 SWRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (689) (290) (399) (315) (374)
Any illegal drugs1 2.0 2.5 1.4 2.3 1.6
Cannabis 1.8 2.5 1.0 1.9 1.6
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.2 0.3 0.0 0.0 0.3
Other opiates2 0.9 0.6 1.3 1.1 0.8
Cocaine  
(total including crack) 0.3 0.0 0.6 0.6 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.3 0.0 0.6 0.6 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.0 0.0 0.0 0.0 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.1 0.0 0.2 0.0 0.2
Sedatives & 
tranquillisers 2.5 1.6 3.5 1.9 3.2
Anti-depressants 3.6 2.0 5.1 3.5 3.6
Alcohol 77.4 81.1 73.5 76.0 78.9
Tobacco 33.6 32.4 34.8 36.3 30.6
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 16 – Ireland Southern RDTF (SRDTF)
Table 16.1 SRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (682) (302) (380) (239) (443)
Any illegal drugs1 16.3 19.8 12.7 22.1 11.6
Cannabis 15.0 17.9 12.0 20.1 10.8
Heroin 0.1 0.0 0.3 0.3 0.0
Methadone 0.1 0.0 0.3 0.3 0.0
Other opiates2 5.2 4.2 6.2 2.5 7.3
Cocaine  
(total including crack) 3.1 4.9 1.2 5.3 1.3
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 3.1 4.9 1.2 5.3 1.3
Amphetamines 2.6 4.2 1.0 4.6 1.0
Ecstasy 3.5 4.9 2.0 5.9 1.4
LSD 1.2 1.6 0.8 1.7 0.7
Magic mushrooms 3.4 4.9 2.0 5.6 1.7
Solvents 1.0 1.6 0.5 2.0 0.3
Poppers3 2.8 3.9 1.7 4.9 1.1
Anabolic Steroids 0.3 0.5 0.2 0.5 0.2
Sedatives & 
tranquillisers 9.7 8.5 10.9 3.6 14.6
Anti-depressants 6.8 6.0 7.7 4.9 8.4
Alcohol 87.2 88.6 85.7 89.1 85.7
Tobacco 54.7 51.7 57.7 51.9 56.9
Table 16.2 SRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (682) (302) (380) (239) (443)
Any illegal drugs1 4.9 7.4 2.4 9.5 1.3
Cannabis 4.6 6.9 2.1 8.6 1.3
Heroin 0.1 0.0 0.3 0.3 0.0
Methadone 0.1 0.0 0.3 0.3 0.0
Other opiates2 1.7 1.1 2.3 0.0 3.1
Cocaine  
(total including crack) 1.1 1.8 0.5 2.5 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 1.1 1.8 0.5 2.5 0.0
Amphetamines 0.2 0.5 0.0 0.5 0.0
Ecstasy 0.6 1.2 0.0 1.0 0.3
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.7 1.4 0.0 1.5 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.2 0.5 0.0 0.5 0.0
Anabolic Steroids 0.2 0.5 0.0 0.5 0.0
Sedatives & 
tranquillisers 4.2 3.9 4.4 1.8 6.2
Anti-depressants 3.7 4.1 3.2 2.4 4.7
Alcohol 81.3 84.8 77.7 82.3 80.6
Tobacco 30.1 26.6 33.7 32.8 27.9
Table 16.3 SRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (682) (302) (380) (239) (443)
Any illegal drugs1 2.0 3.7 0.2 3.5 0.7
Cannabis 2.0 3.7 0.2 3.5 0.7
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0
Other opiates2 0.5 0.3 0.7 0.0 0.9
Cocaine  
(total including crack) 0.2 0.4 0.0 0.5 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.2 0.4 0.0 0.5 0.0
Amphetamines 0.0 0.0 0.0 0.0 0.0
Ecstasy 0.2 0.5 0.0 0.5 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.0 0.0 0.0 0.0 0.0
Sedatives & 
tranquillisers 2.8 2.6 3.0 1.0 4.3
Anti-depressants 2.8 3.1 2.5 2.0 3.5
Alcohol 69.7 76.6 62.6 68.7 70.6
Tobacco 27.2 25.0 29.5 29.6 25.2
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 17 – Ireland Western RDTF (WRDTF)
Table 17.1 WRDTF – Lifetime Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (543) (214) (329) (216) (327)
Any illegal drugs1 23.3 28.6 17.7 31.7 16.4
Cannabis 21.0 26.1 15.8 29.1 14.5
Heroin 0.2 0.0 0.3 0.3 0.0
Methadone 0.2 0.0 0.3 0.3 0.0
Other opiates2 3.9 3.3 4.4 3.6 4.1
Cocaine  
(total including crack) 3.5 3.5 3.5 6.7 0.9
Crack 0.5  0.7 0.3 1.1 0.0
Cocaine Powder 3.2 2.8 3.5 6.0 0.9
Amphetamines 2.9 3.3 2.5 5.1 1.1
Ecstasy 4.4 4.6 4.1 8.1 1.3
LSD 2.3 2.8 1.9 3.7 1.2
Magic mushrooms 3.2 3.0 3.5 5.2 1.6
Solvents 1.8 3.0 0.6 2.2 1.6
Poppers3 3.0 3.5 2.5 6.0 0.6
Anabolic Steroids 0.4 0.0 0.9 0.3 0.5
Sedatives & 
tranquillisers 9.9 10.4 9.3 7.6 11.8
Anti-depressants 10.0  8.2 11.9 8.5 11.2
Alcohol 90.5 92.0 89.0 91.6 89.6
Tobacco 63.0 65.7 60.3 60.4 65.2
Table 17.2 WRDTF – Last Year Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (543) (214) (329) (216) (327)
Any illegal drugs1 4.7 5.6 3.8 8.1 2.0
Cannabis 4.3 5.0 3.5 7.1 2.0
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.2 0.0 0.3 0.3 0.0
Other opiates2 1.1 1.0 1.2 1.1 1.1
Cocaine  
(total including crack) 1.5 1.1 1.9 3.0 0.3
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 1.5 1.1 1.9 3.0 0.3
Amphetamines 0.4 0.5 0.3 0.6 0.3
Ecstasy 0.9 1.1 0.6 1.9 0.0
LSD 0.4 0.5 0.3 1.0 0.0
Magic mushrooms 0.6 0.5 0.6 1.3 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.3 0.5 0.0 0.6 0.0
Anabolic Steroids 0.3 0.0 0.5 0.3 0.2
Sedatives & 
tranquillisers 4.9 6.3 3.3 2.8 6.5
Anti-depressants 5.9 6.1 5.6 5.0 6.6
Alcohol 82.6 85.0 80.2 86.4 79.6
Tobacco 38.0 37.0 39.1 40.2 36.3
Table 17.3 WRDTF – Last Month Prevalence (%)
Drug
All 
adults 
15-64 Males Females
Young 
adults 
15-34
Older 
adults 
35-64
Total Sample 
(Unweighted) (543) (214) (329) (216) (327)
Any illegal drugs1 1.6 2.5 0.6 3.2 0.3
Cannabis 1.6 2.5 0.6 3.2 0.3
Heroin 0.0 0.0 0.0 0.0 0.0
Methadone 0.2 0.0 0.3 0.3 0.0
Other opiates2 0.4 0.7 0.2 0.7 0.2
Cocaine  
(total including crack) 0.4 0.5 0.3 1.0 0.0
Crack 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.4 0.5 0.3 1.0 0.0
Amphetamines 0.3 0.5 0.0 0.6 0.0
Ecstasy 0.3 0.0 0.6 0.7 0.0
LSD 0.0 0.0 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0
Poppers3 0.0 0.0 0.0 0.0 0.0
Anabolic Steroids 0.2 0.0 0.3 0.3 0.0
Sedatives & 
tranquillisers 4.0 5.5 2.4 2.5 5.2
Anti-depressants 5.0 4.9 5.1 4.6 5.2
Alcohol 71.2 75.8 66.4 72.1 70.5
Tobacco 32.9 33.4 32.4 33.9 32.1
1 For this study, ‘any illegal drugs’ refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 A change in the measurement of ‘other opiates’ occurred in the 2006/7 survey. Please see Methodology section for further details.
3 Poppers, i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 18.1 – Ireland Overview All Adults 15-64 All RDTF Areas
Table 18.1 Ireland – Lifetime Prevalence (%)
Drug
ECRDTF MRDTF MWRDTF NERDTF NWRDTF NRDTF SERDTF SWRDTF SRDTF WRDTF
02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7
Total Sample 
(Unweighted) (455) (360) (315) (401) (424) (537) (433) (446) (332) (386) (521) (483) (604) (440) (604) (689) (746) (682) (484) (543)
Any illegal drugs1 25.9 38.4 11.0 19.6 12.0 18.0 18.9 22.9 10.6 14.5 29.5 32.2 18.5 25.4 24.0 25.6 12.1 16.3 12.5 23.3
Cannabis 24.5 35.9 10.7 17.0 10.9 17.0 17.8 19.5 9.3 12.8 26.9 28.8 16.8 23.3 23.2 24.0 11.6 15.0 12.0 21.0
Heroin 0.7 0.3 0.3 0.2 0.0 0.3 0.4 0.5 0.0 0.7 0.9 1.5 0.0 0.0 1.8 0.4 0.0 0.1 0.0 0.2
Methadone 0.5 0.8 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.3 1.0 1.0 0.0 0.0 1.2 0.3 0.0 0.1 0.0 0.2
Cocaine 
(total including crack) 6.3 9.1 1.3 4.4 1.1 2.9 1.2 5.6 0.0 1.6 5.2 11.0 2.5 6.7 5.0 3.8 1.9 3.1 1.6 3.5
Crack 1.0 0.9 0.3 0.3 0.0 0.6 0.3 1.4 0.0 1.4 0.6 0.5 0.3 0.5 0.4 0.6 0.0 0.0 0.1 0.5
Cocaine Powder 6.3 9.1 1.3 4.0 1.1 2.9 0.9 4.9 0.0 1.6 5.0 10.7 2.3 6.4 4.7 3.6 1.9 3.1 1.5 3.2
Amphetamines 4.8 3.9 0.6 3.6 1.3 2.6 2.6 3.3 0.3 2.1 3.8 5.5 4.4 6.9 5.1 2.1 1.8 2.6 1.4 2.9
Ecstasy 5.4 7.6 2.0 5.8 1.7 2.9 2.6 5.4 0.3 2.2 6.5 11.2 4.3 6.5 5.9 4.1 2.8 3.5 1.8 4.4
LSD 4.9 4.1 1.6 2.4 1.4 2.3 2.0 3.0 0.3 1.3 4.2 6.3 4.6 4.1 4.9 1.7 1.2 1.2 1.2 2.3
Magic mushrooms 5.9 10.5 1.8 5.5 1.7 3.1 3.2 5.0 1.5 3.0 5.1 11.4 5.7 6.3 5.6 5.4 2.9 3.4 2.0 3.2
Solvents 2.5 2.1 1.2 2.7 0.9 2.2 3.3 2.0 0.7 2.0 3.4 0.9 1.1 3.1 1.6 1.9 1.1 1.0 0.4 1.8
Poppers2 3.6 5.4 1.6 2.6 0.8 1.8 5.0 3.1 0.9 2.6 4.0 5.7 3.3 4.5 3.0 1.9 1.3 2.8 1.3 3.0
Alcohol 94.1 92.8 87.1 90.9 87.5 90.0 87.6 90.6 86.0 90.1 93.5 91.0 89.5 90.5 91.2 90.9 91.2 87.2 88.1 90.5
Tobacco 62.1 59.8 60.4 60.2 58.6 60.0 57.6 58.1 58.5 56.2 62.5 55.4 60.7 59.3 63.8 56.3 54.8 54.7 61.1 63.0
n  cell indicates a significant increase from 2002/3 to 2006/7.
n  cell indicates a significant decrease from 2002/3 to 2006/7.
1 For this study “any illegal drug” refers to the use of amphetamine, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 Poppers i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 18.2 – Ireland Overview All Adults 15-64 All RDTF Areas
Table 18.2 Ireland – Last Year Prevalence (%)
Drug
ECRDTF MRDTF MWRDTF NERDTF NWRDTF NRDTF SERDTF SWRDTF SRDTF WRDTF
02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7
Total Sample 
(Unweighted) (455) (360) (315) (401) (424) (537) (433) (446) (332) (386) (521) (483) (604) (440) (604) (689) (746) (682) (484) (543)
Any illegal drugs1 6.3 12.4 2.8 4.4 3.2 5.8 6.4 5.7 2.6 2.9 8.4 12.8 6.9 7.9 7.5 7.4 4.7 4.9 2.9 4.7
Cannabis 6.1 11.3 2.8 4.1 3.0 4.7 5.2 4.6 2.2 2.9 7.7 11.9 5.8 5.1 7.3 6.7 4.4 4.6 2.0 4.3
Heroin 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.4 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0
Methadone 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.2
Cocaine 
(total including crack) 2.3 2.1 0.3 1.7 0.6 1.0 0.0 1.5 0.0 0.3 1.7 3.3 1.7 2.4 1.5 0. 0.7 1.1 0.7 1.5
Crack 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 2.3 3.1 0.3 1.3 0.6 1.0 0.0 1.1 0.0 0.3 1.7 3.0 1.7 2.4 1.5 0.8 0.7 1.1 0.7 1.5
Amphetamines 0.8 0.0 0.3 0.2 0.0 0.7 0.2 0.5 0.0 0.3 0.3 1.1 0.9 0.6 0.6 0.0 0.4 0.2 0.3 0.4
Ecstasy 2.5 2.3 0.9 0.9 0.6 0.8 0.5 0.9 0.0 0.3 1.6 2.9 1.3 1.9 1.3 0.5 0.9 0.6 0.3 0.9
LSD 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.4
Magic mushrooms 0.0 2.0 0.3 0.3 0.0 0.4 0.5 0.0 0.4 0.3 0.9 1.1 0.8 0.6 0.3 0.2 0.3 0.7 0.0 0.6
Solvents 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers2 1.0 0.3 0.0 0.0 0.0 1.3 1.2 0.6 0.0 0.3 0.3 1.0 0.7 0.8 0.2 0.0 0.1 0.2 0.3 0.3
Alcohol 89.2 86.1 78.6 83.5 81.2 82.7 82.3 84.4 77.0 78.6 88.8 87.9 83.7 83.2 86.0 87.1 85.1 81.3 77.1 82.6
Tobacco 39.2 38.7 36.5 39.5 35.7 38.9 34.6 37.2 32.9 32.3 42.9 37.2 38.2 35.0 43.8 37.9 34.8 30.1 36.2 38.0
n  cell indicates a significant increase from 2002/3 to 2006/7.
1 For this study “any illegal drug” refers to the use of amphetamine, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 Poppers i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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Prevalence Table 18.3 – Ireland Overview All Adults 15-64 All RDTF Areas
Table 18.3 Ireland – Last Month Prevalence (%)
Drug
ECRDTF MRDTF MWRDTF NERDTF NWRDTF NRDTF SERDTF SWRDTF SRDTF WRDTF
02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7 02/3 06/7
Total Sample 
(Unweighted) (455) (360) (315) (401) (424) (537) (433) (446) (332) (386) (521) (483) (604) (440) (604) (689) (746) (682) (484) (543)
Any illegal drugs1 4.1 5.3 1.0 1.7 1.6 1.4 2.4 1.1 0.2 0.3 5.3 8.2 3.1 3.6 4.3 2.0 2.1 2.0 1.9 1.6
Cannabis 3.8 4.2 1.1 1.1 1.6 1.4 1.9 0.8 0.2 0.3 4.5 7.9 2.1 2.8 3.9 1.8 2.1 2.0 1.3 1.6
Heroin 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0
Methadone 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.2
Cocaine 
(total including crack) 0.5 0.8 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.4 0.0 0.9 0.6 0.3 0.4 0.2 0.4 0.4
Crack 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cocaine Powder 0.5 0.8 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.8 1.4 0.0 0.9 0.6 0.3 0.4 0.2 0.4 0.4
Amphetamines 0.5 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.3
Ecstasy 0.9 0.5 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.3 1.0 1.3 0.3 0.0 0.0 0.2 0.2 0.3 0.3
LSD 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0
Magic mushrooms 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0
Solvents 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Poppers2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Alcohol 81.2 77.2 69.0 70.3 71.8 72.2 71.2 73.2 67.6 64.9 80.7 78.3 74.1 72.6 73.5 77.4 75.3 69.7 67.0 71.2
Tobacco 32.0 32.4 31.4 36.2 29.8 35.9 31.1 35.1 28.6 28.0 38.3 34.8 32.5 31.6 39.4 33.6 31.5 27.2 31.7 32.9
n  cell indicates a significant increase from 2002/3 to 2006/7.
n  cell indicates a significant decrease from 2002/3 to 2006/7.
1 For this study “any illegal drug” refers to the use of amphetamine, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
2 Poppers i.e. amyl or butyl nitrite.
Note: Unweighted sample sizes for each group are given at the head of each column. All prevalence rates are based on weighted data. All figures are rounded to the nearest decimal place.
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